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Abstract 
 
 Iron is an essential element for most pathogenic bacteria. To survive and 
establish infections in host tissues, these pathogens must compete with the host 
organism for iron. One strategy is to excrete iron-chelator siderophores with very 
high affinity to ferric iron in the low iron environment of the host. The phenolate type 
siderophore, such as pyochelin in Pseudomonas aeruginosa, uses salicylate derived 
from chorismate as a precursor. Studies have shown that the salicylate activation by 
adenylation for incorporation to siderophores is associated with the growth and 
virulence of some pathogens. The inhibition of salicylate biosynthesis, and hence, 
siderophore production is considered an attractive target for the development of novel 
antimicrobial agents. 
 In P. aeruginosa, salicylate is derived from chorismate via isochorismate by 
two enzymes: isochorismate synthase (PchA) and isochorismate-pyruvate lyase (IPL, 
PchB). PchB eliminates the enolpyruvyl side chain from isochorismate through a 
biologically unusual pericyclic reaction mechanism. PchB can also perform an 
adventitious pericyclic reaction that rearranges chorismate to prephenate possibly due 
to the homology to the E. coli chorismate mutase (CM). The primary contribution to 
lower the activation energy for enzymatic pericyclic reactions is controversial and 
may be arise from electrostatic stabilization of the transition state, or conformational 
stabilization of the reactive substrate. Structural and mutational studies on a key 
residue, lysine 42, of the active site loop suggest that rate enhancement of the two 
 
 iv
pericyclic reactions (IPL and CM) performed by PchB results from both the transition 
state stabilization and the reactive substrate conformation, but the relative 
contributions are different for each reaction. A mutation with less active site loop 
mobility, A43P indicates that the loop dynamics is related to catalysis. The I87T 
structure reveals a larger disordered region compared to the wild type structure, 
suggesting that conformational mobility may play a role in catalysis. 
 PchA is an isochorismate synthase (ICS) in P. aeruginosa that removes the C4 
hydroxyl group and adds a hydroxyl group to C2-chorismate. PchA is homologous to 
salicylate synthases from Yersinia spp. and Mycobacterium tuberculosis that convert 
chorismate to salicylate without requirement of an additional lyase such as PchB in P. 
aeruginosa. A sequence comparison between PchA with salicylate synthases of 
known structure suggests that two conserved residues are directly involved in the 
general acid and base chemistry in PchA: K221 as the general base and E269 as the 
general acid. Replacement of K221 and E269 with alanine respectively led to 
catalytically inactive enzymes, suggesting that K221 and E269 are critical for ICS 
catalysis. Preliminary pH dependence data for PchA supports the general acid and 
base mechanism of PchA catalysis. Two nonconserved residues A375 and D310 were 
also examined. Replacement of A375 by threonine, the corresponding residue in 
salicylate synthase, resulted in only residual ICS activity, indicating that A375 is not 
associated with the IPL-deficiency in PchA. The D310E mutant leads to two 
additional activities, IPL and CM. The additional activities in three reactions may due 
to the preferential orientation of substrates in the active site. 
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CHAPTER 1 
 
Introduction 
 
1.1 Bacterial Infections 
 Among millions of different kinds of bacteria, only small subsets of them 
cause diseases and are referred to as pathogens. The work described in this 
dissertation will be relevant to pathogens Pseudomonas aeruginosa, Yersinia 
enterocolitica, and Yersinia pestis. 
 P. aeruginosa is a ubiquitous gram-negative bacterium that widely resides in 
nature including soil, water, plants, and animals. This opportunistic bacterium rarely 
causes infection in healthy people. Immunocompromised individuals are much more 
susceptible to opportunistic infections by P. aeruginosa, such as patients with severe 
burn, AIDS, or cystic fibrosis (CF) disease. P. aeruginosa outbreaks are responsible 
for a death rate of ~60% in patients with severe burns who have disrupted physical 
barriers to pathogen invasion.1 In AIDS patients, secondary infections caused by P. 
aeruginosa are a major cause of death.2 CF patients provide an excellent habitat for 
chronic microbial colonization in the airways. P. aeruginosa is the major pathogen 
found in CF patients and causes chronic lung infections associated with high rates of 
illness and death in CF patients.3 P. aeruginosa is also responsible for nosocomial 
infections. P. aeruginosa infections are very hard to deal with because of a variety of 
virulence factors produced, the formation of biofilm, and their innate resistance to 
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many antibiotics. 
 Y. enterocolitica and Y. pestis are gram-negative bacteria that belong to the 
family Enterobacteriaceae. Y. enterocolitica is a versatile enteric pathogen that  
usually infects hosts through contaminated food and water. Y. enterocolitica 
infections cause acute enteritis associated with fever, abdominal pain and diarrhea , 
particularly in children.4 Various antibiotics are available for the treatment in patients 
with Y. enterocolitica infection.5 Y. pestis is historically famous as an etiologic agent 
of European Black Death (the plague) during the 14th century, resulting in a loss of 
approximately 30 to 40% of the population.6 Y. pestis is an obligate parasite and is 
primarily transmitted by fleas from infected rodents or other wild mammals to 
humans. Y. pestis grows in the regional lymph nodes after transmitted to humans, 
causing swollen lymph nodes followed by continued growth in the blood and other 
organs.6 Patients with plague can be treated by antibiotics treatments, such as 
streptomycin, tetracycline, chloramphenical, etc.6  
 Bacterial drug resistant species have been documented, including P. 
aeruginosa and Yersinia spp. To develop new antimicrobial reagents, the iron uptake 
pathway is of interest due to no current reagent specifically designed to inhibit this 
pathway. 
  
1.2 Bacterial Iron Uptake 
The Importance of Iron 
 Iron is an essential element for most living organisms and a growth-limiting 
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factor for the majority of microorganisms. Iron can adopt two positively charged 
ionic forms, Fe2+ (ferrous iron) and Fe3+ (ferric iron). Many enzymes involved in 
metabolic processes require iron-containing cofactors, for example, iron-sulfur 
clusters and heme groups, as a catalytic center or an electron carrier. Thus iron is 
important for a variety of cellular events, including photosynthesis, respiration, the 
tricarboxylic acid cyclic, oxygen transport, and gene regulation.7  
 Ferrous iron is soluble in solution at pH 7.0. If this reduced ferrous form could 
be maintained, Fe2+ would be sufficient for living cells. Under anaerobic or reducing 
conditions, Fe2+ diffuses easily through porins on the outer membrane of gram-
negative bacteria, and then across the cytoplasmic membrane via an ABC ferrous ion 
transporter.8 However, under aerobic conditions, Fe2+ is unstable and is oxidized to 
Fe3+, which releases reactive hydroxyl radicals that are toxic for most biological 
macromolecules.9 At physiological pH 7, Fe3+ forms insoluble ferric oxide hydrate 
complexes, leading to a free Fe3+ concentration of 10-9 to 10-18 M. In mammalian 
hosts, ferric iron is tightly sequestered into various proteins such as hemoproteins, 
ferritins, lactoferrin, and transferrin. Iron homeostasis is so strictly regulated that the 
concentration of free iron in the mammalian hosts is only about 10-18 ~ 10-24 M.10 
Thus, in order to colonize hosts and establish infections, pathogenic bacteria must 
acquire iron from its host. Under conditions of iron starvation, these bacteria have 
evolved several elaborate mechanisms to scavenge iron from their environment 
through high affinity iron acquisition systems composed of siderophores, outer 
membrane receptors, periplasmic binding proteins, ATP-binding cassette transporters, 
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and the TonB-ExbB-ExbD protein complex (Figure 1-1). Iron overload is harmful to 
bacteria, so iron uptake is strictly regulated through repressors of genes involved in 
iron uptake systems.11 
 
Iron Uptake from Host Transferrin/Lactoferrin 
 Transferrin and lactoferrin are homologous iron-binding glycoproteins. Gram-
negative pathogenic bacteria, such as Neisseria and Haemophilus, have a conserved 
mechanism to extract ferric iron from transferrin and lactoferrin through outer 
membrane receptors for these two glycoproteins.12 The extraction events take place 
on the cell surface via receptors TbpB/TbpA for transferrin, and LbpB/LbpA for 
lactoferrin.13 TbpB and LbpB are attached to the outer membrane by a lipid anchor 
and function as the initial reorganization site of transferrin and lactoferrin.14 Boulton 
et al.15 have proposed a dynamic model in which TbpB initially recognizes and binds 
transferrin, which might facilitate transferrin binding to TbpA. Binding of 
transferrin/lactoferrin to TbpA/LbpA leads to a conformational change of 
transferrin/lactoferrin, and then release of iron. After transportation across the outer 
membrane, ferric ion binds to ferric iron binding protein (FBP) and is shuttled 
through the cytoplasmic membrane via an inner membrane ABC transporter (Figure 
1-1).16 
 
Heme as An Iron Source 
 In a host organism, iron is often incorporated into heme, a prosthetic group in  
  
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1. A schematic view of iron uptake in gram-negative bacteria. ABC 
transporters on the inner membrane are represented as BtuCD (PDB code 
1L7V) and the siderophore receptor is represented as FptA (PDB code 
1XKW). 
  
6 
many host intracellular carrier proteins. Pathogenic bacteria secrete exotoxins such as 
cytolysins and hemolysins to disrupt cell membranes and release heme during 
infection.17, 18 Two mechanisms have been proposed for heme uptake in gram-
negative bacteria (Figure 1-1). The first mechanism, the direct uptake of heme or 
hemoproteins requires a TonB dependent outer membrane receptor. The receptor 
HmbR of Neisseria meningitides transports hemoglobin and heme, whereas HemR of 
Y. enterocolitica is capable of transporting heme and many hemoproteins, such as 
hemoglobin, myoglobin, hemopexin, etc.19 To move heme and hemoproteins into the 
cytoplasm, a periplasmic binding protein (PBP), and an ABC transporter are also 
required.19 The second mechanism used by gram-negative bacteria is to secrete small 
heme-binding proteins (hemophores) that can scavenge heme from the host. This 
heme acquisition system 20 has been identified in several pathogens such as P. 
aeruginosa and Yersinia sp.12, 21 Hemophore HasA from Serritia marcescens is 
secreted into the extracellular environment through an ABC transporter complex 
(HasD-HasE-HasF).12, 20 HasA binds either free heme or extracts it from 
hemoproteins and then is transported through the receptor HasR that also recognizes 
free heme.22 Once inside the cytoplasm, ferric iron is release upon heme degradation 
by heme oxygenase.23 
 
Siderophores 
 Siderophores are low molecular weight molecules (500 ~ 1000 Da) produced 
in microorganisms and some plants that chelate ferric iron with particularly high 
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affinity (Ka range from 1023 to 1030 M-1).7 Almost 500 different siderophores from 
gram-negative and gram-positive bacteria have been identified.24 Despite the diversity 
in their overall structures, siderophores primarily use three types of chemical groups 
to coordinate the ferric iron. Based on the chemical properties of these iron-chelating 
groups, siderophores are classified as: hydroxycarboxylate, catecholate-phenolate, 
and hydroxamate types (Figure 1-2). Some siderophores integrate more than one 
chemical group from the three classes, resulting in a mixed type siderophore. A 
siderophore molecule provides six coordination sites to an iron due to ferric iron’s 
electronic configuration. The Fe-coordinating atom in siderophores is primarily 
oxygen.25 
 Studies have found that siderophore production is associated with virulence in 
several pathogenic bacteria.4, 26-28 Siderophores regulated production of the virulence 
factors required for colonization and lethality during P. aeruginosa infection.26, 27  
Yersiniabactin, a siderophore produced by Y. enterocolitica was found to only be 
expressed in the mouse lethal strains, indicating that the virulence was strictly related 
to siderophore production.28 
 
Nonribosomal Peptide Synthesis 
  Siderophores are primarily assembled by nonribosomal peptide synthetase 
(NRPS) machineries in the cytoplasm. NRPSs are large multifunctional enzymes that 
consist of modules; each module catalyzes one cycle of peptide chain elongation. A 
module is composed of several domains that are responsible for a single step during the 
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Figure 1-2: Representative siderophore structures. Catecholate-phenolate type 
siderophores coordinate Fe3+ using adjacent hydroxyl groups of catechol rings 
(green and blue circles); hydroxamate type siderophores bind Fe3+ via a carbonyl 
group with an adjacent nitrogen (purple circles), and citrate-derived !-hydroxy-
carboxylates are circled in red in hydroxycarboxylate type siderophore.   
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chain elongation. The classical module has an adenylation domain (A), a peptidyl 
carrier domain (PCP), a condensation domain (C), and editing domains (Figure 1-3).  
An amino acid is adenylated by the A domain and tethered to the 4!-
phosphopantetheine (Ppant) group of the PCP domain. The Ppant group shuttles the 
peptide intermediate between catalytic centers that catalyze peptide bond formation in 
the C domain and modification of the incorporated amino acid in the editing domain. 
The editing domains give rise to the diversity and stability of siderophores, such as 
epimerization L-amino acid to D-amino acid, methylation of the peptide bond,  and 
alteration of the oxidation state in oxazoline and thiazoline rings. A thioesterase (TE) 
domain is usually found at the C-terminal of last module of NRPS assembly line, 
serving as an end point of peptide elongation through hydrolysis or cyclization.29, 30 
 
Siderophore Transport 
 Siderophores are too big to freely diffuse across the inner and outer 
membranes in gram-negative bacteria, so membrane transporters are required for 
siderophore secretion. The mechanism of siderophore secretion is proposed to require 
energy. The exporters involved in the outflow of siderophores have only been 
identified in several bacteria. Enterobactin secretion by E. coli requires an efflux 
pump of the major facilitator superfamily (MFS) on the inner membrane and a 
channel protein on the outer membrane.31 Once in the environment, the siderophore 
extracts iron from the host, forming a Fe3+-siderophore complex that is recognized by 
an outer membrane receptor. Structures of several Fe3+-siderophore receptors have been 
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Figure 1-3: Representation of one cycle of the peptide chain 
elongation on a module of NRPS. ! The amino acid is activated 
by adenylation by the A domain. " The activated adenylyl amino 
acid is covalently attached to the thiol group of the Ppant arm on 
the PCP domain. #The C domain catalyzes peptide formation 
between the donor and acceptor amino acids. $ Modification of 
the amino acid (aa2) by the E domain in this case, to convert L- to 
D- configuration. % D-aa2 is loaded to the donor site on the C 
domain of next module. Abbreviations: A, adenylation domain; 
PCP, peptidyl-carrier domain; C, condensation domain; E, 
epimerase domain. (Figure modified from Mootz et al. 2002)   
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determined as "-barrels. Transport of Fe3+-siderophore complex across the outer 
membrane requires energy input from the complex ExbB-TonB-ExbD on the inner 
membrane (Figure 1-1),32 followed by transport into the cytoplasm through an ABC 
transporter. Iron is released in the cytosol by hydrolysis of the Fe3+-siderophore or 
reduction of Fe3+ to Fe2+ that has less affinity for the siderophore.25   
 
Pyochelin Assembly 
 During infection, P. aeruginosa overcomes the iron-limiting condition in 
hosts by secreting two siderophores, pyochelin and pyoverdin. Pyoverdin has a very 
high affinity for ferric iron with an association constant of 1030 M-1, whereas 
pyochelin binds ferric iron with an association constant of 105 M-1.24, 33 Pyoverdin is a 
hydroxamate siderophore composed of 6 ~ 12 amino acids. It has been shown that the 
virulence of P. aeruginosa is regulated and enhanced by the production of 
pyoverdin.26, 27 Pyochelin produced by P. aeruginosa increased the lethality of 
virulent strains but not in nonvirulent strains.34  
 Pyochelin assembly by NRPS requires one salicylate, three ATPs, two 
cysteines, one S-adenosylmethionine (SAM), and one NADPH. The steps of 
pyochelin assembly are shown in Figure 1-4. Six enzymes, PchA, PchB, PchD, PchE, 
PchF, and PchG are involved. The pyochelin precursor, salicylate is generated in a 
two-step process catalyzed by the sequential action of the enzymes PchA and PchB. 
PchA, an isochorismate synthase, converts chorismate from the shikimate pathway 
into isochorismate, followed by isochorismate-pyruvate lyase, PchB to produce salicylate 
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Figure 1-4: Pyochelin assembly line in P. aeruginosa. A. Salicylate formation in a 
two-step process. B. Covalent attachment of the Ppant prosthetic group  to the 
carrier domains and activation of the building blocks through adenylation. C & D. 
Chain elongation through condensation and cyclization. E. Reduction of the 
second thiazoline ring by PchG and N-methylation of thiazolidine ring. F. 
Pyochelin maturation by hydrolysis and release from the last domain of PchF.  
Abbreviations: ArCP, aryl-carrier domain; Cy, cyclization domain; MT, 
methyltransferase domain; TE, thioesterase domain; Red, reductase. (Figure 
modified from Quadri et al., 1999) 
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and pyruvate (Figure 1-4A). The assembly of pyochelin starts with PchD, an 
adenylation domain that activates salicylate. PchE and PchF undergo posttranslational 
modification by covalent attachment of the Ppant group from coenzyme A to their 
PCP domains and aryl-carrier (ArCP) domains (Figure 1-4B). Activated salicylate is 
transferred to the ArCP domain of PchE (Figure 1-4C). The cyclization (Cy) domain 
of PchE condenses the salicylate with the first cysteine as well as heterocyclizes to 
form a thiazoline ring, which is followed by conversion of L-cysteine to D-cysteine by 
the epimerization (E) domain (Figure 1-4D). The peptidyl product is condensed with 
the second cysteine that is continuously cyclized to a thiazoline ring by the Cy 
domain in PchF. PchG is a NADPH-dependent reductase that reduces the second 
thiazoline ring to a thiazolidine ring,35, 36 which act as a nucleophile that facilitates the 
methyl group transfer from SAM to the thiazolidine ring by the methyl transferase 
domain of PchF (Figure 1-4E). The completed pyochelin is released from PchF via 
the TE domain (Figure 1-4F).37 
 
Yersiniabactin Assembly 
 Yersiniabactin (Ybt) from Yersinia spp. is a mixed nonribosomal peptide and 
polyketide with a Ka of 1036 M-1 for ferric iron.38 Ybt assembly requires not only 
NRPSs but also a PKS (polyketide synthase) component (Figure 1-5).29 Four proteins 
catalyze the condensation of one salicylate, three cysteines, and one malonate into a 
Ybt molecule with consumption of five ATPs, three SAMs as methyl group donor, 
and one NADPH.39  
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Figure 1-5: Yersiniabactin assembly in Y. enterocolitica. A. Salicylate formation from 
chorismate catalyzed by Irp9. B. Activation and covalent attachment of the acyl 
building blocks to the carrier domains. C & D. Chain elongation through condensation 
and cyclization. E. Peptidyl chain transfer from the last module of HMWP2 to the 
PKS module of HMWP1. A malonyl moiety is loaded to the peptidyl chain. Double 
methylation of C2 on the intermediate-PKS and incorporation of the last cysteine. F. 
Methylation of the C! of the thiazolinyl-S-PCP3 intermediate, reduction of the second 
thiazoline ring by Irp3, and hydrolysis to release  of  mature yersiniabactin by TE 
domain. The PKS module is composed of a keto synthase domain, an acyltransferase 
domain, a MT domain, a ketoreductase domain, and an acyl-carrier domain. (Figure 
modified from Miller et al. 2002) 
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 Proteins involved in Ybt synthesis have very high sequence homology 
between Y. enterocolitica and Y. pestis. The assembly line for Ybt is composed of 
Irp5, high-molecular-weight proteins 1 and 2 (HMWP1 and HMWP2), and Irp3 in Y. 
enterocolitica. Prior to Ybt assembly, salicylate is generated from chorismate in a 
single step catalyzed by a salicylate synthase Irp9 (Figure 1-5A)40, which is different 
from the two-step reaction carried out by PchA and PchB in pyochelin biosynthesis in 
P. aeruginosa. Salicylate is then adenylated and transferred to the ArCP domain of 
HMWP2, ready for peptidyl chain elongation (Figure 1-5B). The Ybt is assembled on 
the HMWP1 and HMWP2 protein complex. HMWP2 has two NRPS modules that are 
responsible for incorporation of two cysteine units to salicylate (Figure 1-5C and 1-
5D), which is similar to the elongation steps during pyochelin synthesis. The 
remaining steps for the formation of Ybt take place on HMWP1. First, the 
intermediate tethered to the PCP2 domain in the last module of HMWP2 needs to be 
transferred to the PKS module of HMWP1. Instead of an amino acid, malonate is 
activated and loaded onto acyl-carrier domain of PKS. The keto synthase domain of 
PKS catalyzes the condensation reaction to form a C-C between the intermediate on 
the PCP2 domain and the malonyl group, switching from the NRPS system to the 
PKS system (Figure 1-5E). Second, methyl groups from SAMs are attached to the 
malonyl group by a MT domain and "-keto is reduced by the ketoreductase domain 
on PKS module (Figure 1-5E). Third, the assembly is switched back to the NRPS 
from the PKS, in which the last cysteinyl group is added and cyclized. The last 
methylation on C# of the thiazolinyl-PCP3 is carried out by the MT domain of the last 
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module on HMWP1. Finally, the middle thiazoline ring is reduced into a thiazolidine 
ring by the NADPH-dependent reductase Irp3, followed by the release of complete 
Ybt from the HMWP1 through action of the TE domain (Figure 1-5F).     
  
1.3 Enzyme Active Site and Catalysis 
 Enzymes catalyze biochemical reactions in almost all physiological processes 
in living organisms. All known enzymes are proteins with exception of some catalytic 
RNAs. Enzyme catalysis can accelerate reaction rates as large as a factor of 1019.41 
Under biologically relevant conditions, uncatalyzed biochemical reactions happen 
slowly with rate constants range from 10-17 to 10-1 s-1, whereas rate constants (kcat) of 
enzyme-catalyzed reactions range from 10 to 107 s-1.42 Enzymes provide a sheltered 
environment, active sites, where specific substrates bind and chemical reactions take 
place to produce specific reaction products. Both rate enhancement and substrate 
specificity allow enzymes perform the chemical reactions in metabolism with 
efficiency and accuracy for cells. 
 
Enzyme Active Site 
 During enzymatic catalysis, the formation of an enzyme-substrate complex 
(ES) is the first step followed by formation of an enzyme-transition state complex 
(ES‡), an enzyme-product complex, and finally release of product from enzyme. All 
those processes take place in an active site through direct contacts between the 
substrate and its active site.  
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 In the active site, amino acids side chains, cofactors, or coenzymes are 
arranged in a precise position that in some ways complements the structure and 
charge of the substrate molecule. During an enzyme-catalyzed reaction, various types 
of chemical reactions happen between substrates and functional groups of enzymes. 
Functional groups that provide chemical catalysis include metal ions, coenzymes, and 
the carboxyl, amino, imidazole, hydroxyl, and thiol groups of amino acid side chains. 
These functional groups are involved in hydrogen bonding and electrostatic 
interactions with substrates and also serve as acid-base, nucleophilic, and 
electrophilic catalysts. A transient covalent bond may be formed between catalytic 
functional groups and a substrate to promote the reaction, or a group may be 
transiently transferred from the substrate to the enzyme in the active site. Covalent 
interactions between enzymes and substrates provide an alternative reaction pathway 
to lower the activation energies of reactions, leading to rate enhancement.43  
 
Conformational Mobility in Enzyme 
 An enzyme is a structurally dynamic system in which internal motions are 
important for its function. Some motions may associate with global conformational 
change.44 Enzymes were thought to be rigid molecules that must have an active site 
shape that exactly complements to that of the substrate, known as the lock and key 
model. However, the interactions between the enzyme and substrate are far more 
complex. In most cases, the active site does not have the exact shape of substrate. 
When the substrate approaches the active site, the enzyme is induced to slightly 
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change its active site conformation to best fit the substrate. This change also puts 
strains on the substrate molecule, promoting bond-breaking and bond-making towards 
the transition state. This type of interaction is described as an induced-fit model.45 In 
other words, the enzyme’s active site best accommodates the structure of substrate at 
the transition state rather than the ground state. Motions of the active site help with 
transition state formation and also provide stabilization to the transition state.46 
 
Transition State Theory for Enzyme Catalysis 
 For a chemical reaction, the transition state is the unstable species that  has the 
characteristics of partially broken and partially formed covalent bonds. The transition 
state is at the highest point on the reaction coordinate diagram and is a key factor that 
would affect the reaction rate (E‡ in Figure 1-6). Enzyme-catalyzed reaction differs 
from its counterpart reaction in solution in the formation of ES binary complex and 
the transformation into the ES‡.  
 The binding of a substrate to an enzyme (formation of the ES complex) is 
most likely noncovalent through hydrogen bonding, hydrophobic, electrostatic, and 
van der Waals interactions. These weak, noncovalent interactions between the 
enzyme active site and substrate are considered the major source of the energy 
required to lower the activation free energy barriers of reactions. In 1946, before 
structural information was available, Linus Pauling47 proposed that enzymes bind the 
transition state (TS) better than the corresponding ground state. This means that 
interactions between the enzyme active site and the transition state are optimized for  
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!GN‡ 
!GE‡ 
Figure 1-6: Reaction diagram for a single-substrate 
reaction in solution (black) and catalyzed by an 
enzyme (red). The terms !GN‡ and !GE‡ correspond to 
the activation energies for the uncatalyzed reaction in 
solution and its counterpart catalyzed by the enzyme, 
respectively. (Figure modified from Voet et al. 2005) 
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stabilizing the TS, hence lowering the activation energy and accelerating the reaction 
(Figure 1-6). For decades, experimental evidence support the idea that the 
stabilization of the transition state is the origin of the rate enhancement by enzymes 
and the primary basis for substrate specificity.48 
 A transition state analog (TSA) is a molecule that resembles the transition 
state structure and binds the enzyme much more tightly than corresponding substrate 
and product. Studies of enzymatic reaction mechanisms can provide opportunities for 
rational design of powerful transition state inhibitors. 
 
1.4 Enzyme Catalytic Mechanisms 
 Enzymes affect the rate of reactions, instead of equilibriums.!The rate of a 
chemical reaction primarily depends on the energetic barrier between the substrate 
and the product, the activation energy (!GN‡). Enzymes act by lowering the activation 
energy (Figure 1-6) and allow for rate enhancement of the reaction through one or 
more catalytic mechanisms: 1) general acid and base catalysis, 2) covalent catalysis, 3) 
proximity and orientation effects, and 4) preferential binding of the transition state.45, 
49, 50
 
 
General Acid and Base Catalysis 
 The most common biochemical reactions involve proton transfer at some 
point during the reaction, in which acid and base groups are required for catalysis. 
Reactions catalyzed by protons (from hydronium ion H3O+) or hydroxide ion 
(enclosed by three H2O molecules) in water are the specific acid and base catalysis. 
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However, in the majority of enzyme catalyzed reactions, the Brφnsted-Lowry acidic 
and basic groups of enzymes, or cofactors promote the reactions, which are the 
general acid and base catalysis.45 
 Amino acid with acidic and basic side chains are commonly involved in 
general acid and base catalysis. In the active sites, reactive side chains are in the close 
proximity to the substrate, and positioned precisely controlled relative to the substrate, 
resulting in rate enhancement of 102 to 105.43 The efficiency of general acid and base 
catalysis primarily depends on the pKa of side chains participating in reactions, which 
will be greatly perturbed by the local environment of the active site.42  
 A characteristic feature of general acid and base catalysis is that the transition 
state of the substrate is stabilized by the catalytic groups involved in proton transfer. 
Representations of these transition states are shown in Figure 1-7. In this case, the 
hydrolysis of ester bonds requires formation of a transition state, where an electron is 
partially transferred from water to the ester. The transition state can be stabilized by a 
acidic group/electron-pair acceptor (HA) or a basic group/electron-pair donor (B:).43 
Some enzymes simultaneously employ both general acid and general base 
mechanisms to catalyze a reaction, which has known as a concerted general acid and 
base catalysis.45  
 
Covalent Catalysis 
 In covalent catalysis, enzyme-catalyzed reactions go through the formation of 
a transient covalent intermediate between the enzyme and the substrate.  Formation of   
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Figure 1-7. The transition states for ester hydrolysis 
catalyzed by general acid (A) and general base (B) 
mechanisms. Figure modified from Nelson, D.L. & 
Cox, M.M., 2005. 
A.
. 
B.
. 
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the covalent intermediate brings the reaction along the reaction coordinate toward the 
transition state, and lowers the activation energy of the reaction. The covalent 
catalysis mechanism breaks the reaction into the formation and the breakdown of the 
covalent intermediate instead of catalyzing the single reaction directly.49 Several 
families of enzymes performs this type of mechanism, such as serine proteases (acyl-
serine intermediates), cysteine proteases (acyl-cysteine intermediates), protein kinases 
and phosphatases (phosphor-amino acid intermediates), etc.42 Covalent catalysis is 
performed mainly through nucleophilic and electrophilic pathways. 
 
Nucleophilic Catalysis  
 Nucleophilic catalysis involves a nucleophilic attack on a substrate (group 
being transferred), resulting in a transient covalent intermediate with an electrophilic 
reaction center that is much more reactive than the ground state substrate.42 The 
covalent intermediate can then be attacked by a water or an other molecule to form 
the product and regenerate the functional group of the enzyme.42 Groups being 
transferred normally include acyl groups, phosphoryl groups and glycosyl groups. 
 The reaction rate of nucleophilic catalysis depends on the nucleophilicity 
(electron-donation ability) of the attacking group and the susceptibility of the 
substrate (electrophile).42 The nucleophilicity is primarily determined by the basicity 
of the group (the tendency of a group to donate an electron pair to a proton). The 
nucleophilic reactivity of a group increases with its basicity. Thus, the reaction rate of 
most nucleophilic catalysis is normally correlated with the pKa of the nucleophile. 
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Besides pKa, the chemical nature of the nucleophile, including oxidation potential, 
polarity, ionization potential, electronegativity, and the group size, etc. would also 
determine the reaction rate, features that distinguish nucleophilic catalysis from 
general base catalysis.42, 49 Table 1-1 lists enzyme side chains widely function as 
nucleophiles and examples of covalent intermediates formed during the reactions. 
 
Electrophilic Catalysis/Metal Ion Catalysis 
 In electrophilic catalysis, a substrate reacts with an electrophile and a covalent 
intermediate forms. There are no efficient electrophiles among the amino acids. 
Therefore, enzymes often recruit electron-deficient organic cofactors or metal ions, 
which are coordinated with the substrate or side chains of amino acids as the 
electrophiles. 
  A variety of enzymes utilize divalent metal ions (Fe2+, Cu2+, Zn2+, Mn2+, 
Mg2+, and Ca2+, etc.) in the active sites as electrophilic catalysts.  Metal ions 
participate in electrophilic reactions in several ways: 1) they can electrostatically 
stabilize or shield the negatively charged group of the substrate or the transition state; 
2) they can preferentially bind and help orient reactive groups of the substrate 
properly for reaction, and also act as a bridge that mediates the interaction between a 
substrate and a nucleophilic group; 3) they can perturb the pKa and hence the 
reactivity of nearby nucleophiles; 4) some metal ions can function as an electron 
carrier in the oxidation-reduction reactions by reversible changes in the metal 
oxidation states.43   
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Amino acid Nucleophile Example enzyme Covalent intermediate 
Serine 
 
Serine proteases Acyl-enzyme 
Cysteine  Cysteine proteases Acyl-enzyme 
Aspartate  Coenzyme A transferases CoA-enzyme 
Lysine  Pyridoxal-containing 
enzymes Schiff bases 
Histidine  Phosphoglycerate 
mutase 
Phosphoryl 
enzyme 
Tyrosine  Glutamine synthase Adenyl enzyme 
Table 1-1: Nucleophiles of the amino acid side chains and the covalent 
intermediates formed during catalysis . (Adapted from Frey, 2007) 
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 The $-amino group of lysine can react with carbonyl groups of substrates or 
coenzymes to form imines with higher electrophilic reactivities, which would 
promote the reactions. Pyridoxal phosphate and thiamine pyrophosphate are 
commonly used coenzymes for electrophilic catalysis.49  
 
Proximity and Orientation Effects 
 The general acid and base, or the covalent catalysis chemistry performed in 
the enzyme active site would most likely have counterparts in the organic chemistry 
reaction, which go through the same transition states. Therefore, the great rate 
enhancement of enzyme is in the binding process that happens in the active site. The 
substrate in the active site must go through desolvation and loss of degrees of 
freedom.42 Binding of a substrate to the active site through a series of weak 
interactions would bring the reactant toward the transition state. Those interactions 
can also stabilize the transition state and destabilize the corresponding ground state. 
 In the theory of the proximity and orientation effect, rate acceleration is  
derived from facts that the reactive groups of enzymes and substrates must be 
positioned in an orientation optimal for reaction. Proximity is proposed to increase 
the effective concentrations of substrate when bound in the enzyme active site, which 
by itself counts for relatively a small portion of rate acceleration.45 The reactant 
maximizes its reactivity by changing its geometry such that reacting groups are 
positioned in a proper way, leading to the electronic energy minimum of its transition 
state, and this orientation effect can result in large rate enhancements.45, 51 In other 
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words, the preorganization of the substrate to a reactive conformation followed by the 
stabilization by the enzyme active site would be sufficient to proceed to the transition 
state (ES‡). 
 In a single substrate reaction, the rate is greatly increased when the population 
of the substrate adapts a reactive conformation or a near-attack conformation 
(NAC).52 Dr. Thomas Bruice and his colleagues define NAC as a reactive ground 
state conformer that is similar to the transition state (increase of enthalpy due to the 
formation of new inter or intramolucular interactions), where bond-breaking and 
bond-making have not been initiated. NAC is considered as a door from the ground 
state on the way to the transition state. When an enzyme catalyzes a bimolecular 
reaction, two molecules are brought in close proximity, resulting in a loss of 
translational and rotational motion (loss of entropy),53 thereby lowering the activation 
energy and achieving significant rate enhancement.   
 
Preferential Binding of The Transition State 
 The catalytic mechanisms described so far only account for a certain degree of 
rate enhancement. The major source of catalytic power comes from a preferential 
binding of the transition state rather than the corresponding ground state or product.54 
A thermodynamic cycle representing relationship between various states in the 
uncatalyzed and catalyzed single-substrate reaction is shown in Scheme 1:  
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where kuncat is the first-order rate constant for uncatalyzed conversion of substrate to 
product; KTS is the hypothetical dissociation constant for the transition state. 
According to this cycle, the hypothetical binding of a transition state to its enzyme 
can be expressed as KTS /Km = kuncat/kcat.55 This equation indicates that the more tightly 
an enzyme binds to a substrate in the transition state relative to the ground state, the 
faster the rate of enzyme catalyzed reaction relative to its counterpart reaction in 
solution. The enzyme active site provides an electrostatic environment that can 
accommodate developing charge in the transition state.48, 56  
  An enzyme can recognize the ground state of the substrate. The binding of 
the substrate induces the conformational change in the enzyme, which can constrain 
the substrate and then promote the bond breaking and formation.46 Since an enzyme 
preferentially binds the transition state of the substrate, the transition state analogue 
that resembles the geometry of the transition state is a competitive inhibitor for the 
enzyme. Therefore, the transition state structure can provide a template for the 
synthesis of the transition state inhibitor. 
 
 This dissertation focuses on mechanistic studies of the two enzymes PchB and 
PchA responsible for salicylate biosynthesis in P. aeruginosa. Structural analysis was 
Scheme 1 (Adapted from Mader et al., 1997) 
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also performed in order to assist in the elucidation of catalytic mechanisms for PchB 
and PchA. The goal of this work is to provide the catalysis and structural information 
to support the future work of the design of inhibitors against salicylate biosynthesis in 
pathogenic bacteria.  
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CHAPTER 2 
 
Mechanistic and Structural Studies of PchB, a bifunctional 
Isochorismate-Pyruvate Lyase/Chorismate Mutase from 
Pseudomonas aeruginosa 
 
The work described in this chapter is currently being revised for resubmission to 
Biochemistry. “Structure-function analyses of isochorismate-pyruvate lyase 
from Pseudomonas aeruginosa (PchB) suggest differing catalytic mechanisms 
for the two pericyclic reactions of this bifunctional enzyme”  
Qianyi Luo, Jose Olucha, and Audrey Lamb. 
 
2.1 Introduction 
Salicylate is a precursor of iron chelators, siderophores in pathogenic bacteria, 
such as yersiniabactin in Yersinia spp., mycobactin in Mycobacterium tuberculosis, 
and pyochelin in Pseudomonas aeruginosa.1 Salicylate can be derived from 
chorismate via isochorismate as an intermediate. In P. aeruginosa salicylate is made 
from chorismate in a two-step process by two enzymes: isochorismate synthase 
(PchA) and isochorismate-pyruvate lyase (PchB),2, 3 followed by the incorporation 
into siderophore pyochelin. PchB has no sequence similarity to other pyruvate lyases. 
Instead, PchB is a structural homologue of E. coli chorismate mutase (EcCM) with a 
sequence identity of 20%.4 Therefore, it is not surprising that PchB has an 
adventitious chorismate mutase activity.2 
 Both the isochorismate-pyruvate lyase (IPL) and chorismate mutase (CM) 
activities of PchB catalyze pericyclic reactions, which are unusual in biological 
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systems. These two reactions take place in the same active site where product is 
formed from a single substrate in one chemical step through a pericyclic transition 
state (Figure 2-1). IPL activity eliminates the enolpyruvate side chain from 
isochorismate to produce salicylate and pyruvate using a concerted but asynchronous 
[1,5]-sigmatropic hydrogen transfer mechanism with the cleavage of C3-O7 linkage 
and the hydrogen atom  transfer from C2 to C9 of the enolpyruvate side chain (Figure 
2-1a).5 The non-physiological role of PchB as a chorismate mutase is to catalyze a 
[3,3]-sigmatropic rearrangement of chorismate to prephenate, in which bond-breaking 
at C3-O7 linkage and bond-making between C1-C9 are concerted but asynchronous, 
leading to a transfer of the pyruvate tail from the C3 ether linkage to a C1-C9 linkage 
(Figure 2-1b).6 This non-physiological CM activity of PchB has considerably lower 
catalytic efficiency relative to IPL activity.2 The experimentally measured rate 
enhancement in the physiological CM over the corresponding reaction in solution is 
106 ~ 107-fold,7, 8 but the origin of the catalytic power for these enzymes remains 
controversial.  
 Chorismate mutases from different organisms share only low sequence 
similarity. Based on the secondary structure arrangement, chorismate mutases are 
classified into AroH and AroQ classes. AroQ enzymes are completely helical dimeric 
bundles with buried active sites made of amino acids from both monomers. PchB (P. 
aeruginosa), EcCM (E. coli), ScCM (Saccharamyces cerevisiae), and MtCM (M. 
tuberculosis)9-11 belong to AroQ class (Figure 2-2a & b). A well-studied example of 
the AroH class is the CM enzyme in Bacillus subtilis (BsCM). The BsCM is a 
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Figure 2-1: Reaction schemes of PchB catalyzed reactions. a. Isochorismate 
pyruvate lyase activity via [1,5]-pericyclic hydrogen transfer mechanism. b. 
Chorismate mutase activity via [3,3]-sigmatropic pericyclic rearrangement 
mechanism. Both CM and IPL have the transition states with aromatic 
characteristics. 
a. 
b. 
  
37 
 
 
 
 
 
 
 
 
Figure 2-2: Structures of three chorismate mutases. a. PchB homodimer with 
two equivalent active sites, one of which is displayed. Two pyruvates are yellow 
sticks and H-bond to active site residues. (PDB code 2H9D); b. EcCM 
homodimer. One of the two equivalent active site is shown with the TSA bound. 
(PDB code 1ECM); c. BsCM homotrimer. Three active sites are located at the 
interface of subunits, where the TSA binds. (PDB code 2CHT). TSA, the 
transition state analog oxabicyclic acid  is shown in yellow sticks in panels b and 
c. Figures were created using PyMOL. 
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homotrimer with three monomers folding into pseudo-#/"-barrel.7, 8 Three equivalent 
active sites are located at the interfaces between the subunits (Figure 2-2c). Structures 
of chorismate mutase are diverse, however, by comparison of the active site 
architectures of EcCM and BsCM with a transition state analog (TSA) bound, Lee et 
al. considered that the active sites of CMs were comparable due to charge and shape 
complementarity.9  
 The detailed atomic structure of PchB has been determined. PchB is a structural 
homolog to EcCM. The structure of EcCM with TSA bound in the active site 
suggests that eight charged or polar amino acids are interact with TSA.10 In PchB, 
only five of those amino acids are conserved, which leads to the ability to perform 
both IPL and CM reactions in the same active site. The major difference of the apo-
PchB and pyruvate-bound PchB structures is present in a mobile loop between the 
first and second helices. This loop becomes fully ordered in the pyruvate-bound 
structure. A conserved residue lysine 42 in the loop was found to hydrogen bond to a 
pyruvate in the pyruvate-bound PchB structure (Figure 2-2a) and is proposed to be 
critical for catalysis.4 
 CM has become a popular model system to study the origin of the enormous 
catalytic power of enzymes experimentally and theoretically due to two advantages. 
First, the rearrangement of chorismate to prephenate that is catalyzed by CM has a 
counterpart in solution that proceeds in the same manner as that in active site. Studies 
have demonstrated that both catalyzed and uncatalyzed reactions undergo a concerted 
but asynchronous [3,3]-sigmatropic rearrangement through a chair-like pseudodiaxial 
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transition state (Figure 2-1a).11-14 Second, there are no substrate-enzyme covalent 
bonds formed and broken during the intramolecular rearrangement of chorismate to 
prephenate. Only weak interactions involved.15  
 One way for CM to lower the activation energy and thus speed up the reaction is 
to electrostatically stabilize the polar transition state during catalysis.16, 17 The x-ray 
crystallographic structures of several CMs have been solved. Analysis of the active 
site structures with TSA bound leads to a hypothesis that CM provides an active site 
that can accommodate the developing negative charge on the ether oxygen and the 
cyclohexadiene ring of the polar transition state via electrostatic and H-bonding 
interactions.7, 9-11, 13 The positively charged amino acids in the CMs active sites are 
strategically arranged to orient chorismate to the pseudo-diaxial form previously to 
the chemical reaction.18 Considerable mutagenesis studies that have been carried out 
on the EcCM,19 BsCM,20-23 and ScCM24 support the electrostatic transition state 
stabilization hypothesis, suggesting that a positively charged amino acid residue 
(Lys39 in EcCM, Arg90 in BsCM, and Lys168 in ScCM) is positioned next to the 
ether oxygen of the breaking C3–O7 bond, stabilizing the developing negative charge 
of the transition state. Modification of Lys39 (EcCM) and Arg90 (BsCM) led to 
complete loss of mutase activities. Quantum mechanics/molecular mechanics 
(QM/MM) calculations also demonstrated electrostatic stabilization of the polar 
transition state to be dominant in catalysis.25-28  
 Another hypothesis that the substrate ground state conformation is important for 
catalytic efficiency in CM is mainly based on the computational studies. Dr. Thomas 
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Bruice and co-workers coined the term near attack conformation (NAC) to define a 
reactive substrate conformation for ground state that is required to enter the transition 
state. NAC is a true ground state conformation in which reacting atoms are within a 
distance that is less than/equals to the sum of their van der Waals radii and approach 
at an angle ±15° of the bonding angle in the transition state.29 So one can consider 
that NAC is a transition-state-like ground state conformer30 and a door through which 
reactants must pass on the way to the transition state.31 Once enzyme binds and 
stabilizes the NAC, the catalysis can progress spontaneously without extra 
stabilization of the transition state.29, 31-33   
  PchB is a unique system for the experimentally testing the two hypotheses, 
transition state stabilization (TSS) and NAC, for the catalytic efficiency. PchB 
performs two pericyclic reactions (CM and IPL) in a single active site without any 
substrate-enzyme covalent intermediates involved. Two NACs are formed in PchB 
active site (Figure 2-3), which continue the progress toward two transition states 
(Figure 2-1). PchB with dominant IPL over CM activity is probably a consequence of 
the preorganization of the active site in a shape that prefers to constrain NAC for the 
IPL reaction over that for the CM reaction. However, the relative contributions of 
NAC and TSS to the overall rate enhancement in each reaction need to be 
investigated. The structure of PchB indicates that arginines deep in the active site 
organize the substrate, leading to generation of a NAC for catalysis. The mobile loop 
between the first two helices would have a relationship with catalysis due to the 
ordering of this loop upon substrate binding.4 Lys42, the only active site residue 
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Figure 2-3:  Two near attack conformations formed in PchB active 
site. a. Chorismate mutase reaction (modified from Zhang, X. et al., 
2005), b. Isochorismate-pyruvate lyase reaction.   
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found in the loop is proposed as a key factor for catalysis.4 The strategic placement of 
Lys42 can promote bond breaking at C3-O7 of substrate and stabilize the developing 
negative charge at the ether oxygen in the transition states of CM and IPL reactions.  
 In this chapter, mutagenesis studies focusing on PchB Lys42 were carried out to 
elucidate the importance of positive charge and H-bond at position 42. The results 
obtained add further insight into the rate enhancement that arises from active site-
constrain of a reactive substrate conformation and electrostatic stabilization of the 
transition state. 
    
2.2 Materials and Methods 
Site-Directed Mutagenesis of PchB 
 Site-directed PchB mutants, K42A, K42E, K42Q, K42H, A43P, and I87T were 
constructed from the plasmid pET29b-pchB,4 using the QuikChange Site-directed 
Mutagenesis Kit from Stratagene. Primers and their corresponding complements were 
used (mutated codons were underlined):  
K42A:  5!-GCG TCG CGC TTC GCG GCC AGC GAG GCG-3! 
K42E:  5!-GCG TCG CGC TTC GAG GCC AGC GAG GCG-3! 
K42Q:  5!-GCG TCG CGC TTC CAG GCC AGC GAG GCG-3! 
K42H:  5!-GCG TCG CGC TTC CAT GCC AGC GAG GCG-3! 
A43P:  5!-GCG TCG CGC TTC AAG CCG AGC GAG GCG GCG-3! 
I87T:   5!-C ATC CAC TGG TAC ACC GCC GAG CAG ATC-3! 
All mutations were confirmed by sequence analysis. Plasmids bearing each mutation 
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were transformed into E. coli BL21 (DE3) competent cells for protein overproduction. 
  
Overexpression and Purification of Wild Type and Mutant PchB  
 Protein overexpression and purification were performed as previously described 
for the wild type PchB protein4 with some modifications. The cells were grown in LB 
media at 37 °C with shaking at 250 rpm until OD600 reached ~ 0.8. Protein expression 
was induced with 0.2 mM isopropyl-"-D-thiogalactopyranoside (IPTG). After 3 hours, 
the cells were harvested by centrifugation (4,000 × g, 10 min, 4 °C). The pelleted 
cells were resuspended in 25 mM Tris-HCl pH 8.0 (buffer A) and lysed by sonication 
(Digital Sonifier, Branson). The cellular debris was removed by ultracentrifugation 
(142,000 × g, 45 min, 4 °C) and supernatant was applied to a Q Sepharose Fast Flow 
(Amersham Biosciences) column equilibrated with buffer A for anion-exchange 
chromatography. A linear gradient of 0 – 250 mM NaCl in buffer A was applied to 
the column and PchB protein eluted at approximately 100 mM NaCl. The fractions 
PchB were identified by SDS-PAGE, pooled, and concentrated with an Amicon 
stirred cell (YM-3 membrane). Four to five ml of sample was applied to a HiLoad 
16/60 Superdex 75 gel filtration column equilibrated with 50 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1 mM DTT, and 10% glycerol. The protein concentration was 
determined by Bradford assay. The resulting purity was determined to ~99% by SDS-
PAGE. The purified protein was stored at – 80 °C for use in activity assays and 
crystallization trials. 
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Circular Dichroism Studies  
 Circular dichroism spectra were recorded on a Jasco J-815 spectrometer (Easton, 
MD) at 25 °C. Spectra were measured in 20 mM sodium/potassium phosphate pH 7.0 
with a proteins concentration of 2 ~ 3.5 %M. The samples were measured in a quartz 
cuvette with a path length of 1 cm. Five wavelength scans from 190 nm to 260 nm in 
1 nm steps (signal averaging time 1 s; bandwidth 1 nm) were recorded and averaged. 
The data were corrected by subtracting a buffer blank baseline from the average. 
Mean residue ellipticities (& in degrees•cm2•dmol-1) were calculated as described.34 
The resulting data were smoothed and plotted with KaleidaGraph (Synergy Software). 
 
Protein Crystallization  
 K42A was co-crystallized with salicylate and pyruvate at 18ºC using the 
hanging drop method. Before crystallization, K42A (3.8 mM) was incubated with 38 
mM salicylate and 38 mM pyruvate on ice for 30 min. The drop was made by mixing 
1 µl protein solution with 2 µl well solution consisting of 0.1 M TrisHCl pH 8.5, 2 M 
ammonium phosphate, and 13% glycerol. Crystals grew to about 1 × 0.7 × 0.4 mm in 
one week. I87T was crystallized at 25 ºC by the hanging drop method. Drops were 
made by mixing 1.5 %l of 19 mg/ml I87T protein solution with 1.5 %l of a reservoir 
solution composed of 0.1 M Bis-Tris Propane, pH 6.5, 0.14 M calcium chloride, 23% 
PEG 3350, and 10% glycerol. Long rod-shaped crystals with dimensions up to 0.37 × 
0.06 × 0.05 mm were obtained in one week. 
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Data Collection and Structure Determination 
 For data collection, a K42A crystal from the drop was directly flash cooled in 
the stream of nitrogen gas at -160 ºC. The I87T crystal was transferred to 
cryoprotectant solution (0.1 M Bis-Tris propane, pH 6.5; 0.2 M calcium chloride, 
30% PEG 3350; and 20% glycerol) and flash cooled in the nitrogen gas. X-ray 
diffraction data were collected at cryogenic temperature using a Rigaku RU-H3R 
rotating anode generator equipped with Raxis IV image plate detector at the 
University of Kansas Protein Structure Lab. The exposure time per image was 10 min 
at 1º oscillation steps with a crystal to detector distance of 150 mm. Diffraction data 
were indexed and scaled using HKL program suite.35 Both K42A and I87T crystals 
belonged to the space group P212121 with unit cell dimension a = 48.015 Å, b = 53.15 
Å, c = 82.336 Å for K42A, and a = 54.5 Å, b = 74.7 Å, c = 88.5 Å for I87T. Data 
collection statistics are listed in Table 2-1. 
 The structure of K42A was determined using the molecular replacement 
program Phaser from the CCP4 program suite36 and the PchB pyruvate-bound 
structure (PDB code 2H9D) as a model, with the water and ligands omitted. The I87T 
structure was determined by molecular replacement with the program Auto MolRep, 
also from the CCP4 package.36 The PchB pyruvate-bound structure (PDB code 2H9D) 
was used as the search model. Model building proceeded using Coot37 with cycles of 
maximum likelihood refinement using REFMAC38, both in the CCP4 program 
package. Refinement statistics are in Table 2-1. 
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Unique
Total
Protein, nonhydrogen
Nonprotein
Length (Å)
Angles (°)
20.1
2726
77
0.008
1.02
16,778
0.219
0.256
2
Table 2-1: Crystallographic statistics
Data Collection
K42A with products Apo I87T
Resolution Range (Å) 41.5 - 2.5 100 - 2.15
Space Group P212121 P212121
Unit Cell (Å) a = 48.0, b = 53.2, c = 82.3 a = 54.5, b = 74.9, c = 88.5
Observations
7706 20,232
50,717 345,137
Completeness (%)1 99.9 (99.9) 99.2 (98.6)
Rsym2 0.101 (0.227) 0.108 (0.423)
% > 3 s (I) 85.7 (72.9) 80.4 (55.4)
Refinement
Resolution Range (Å) 41.5 - 2.5 44.24 - 2.25
Number of Reflections 7,346
R-factor 3 0.218
Rfree
4 0.276
Dimers/asymmetric unit 1
Number of  atoms
1580
48
Root mean square deviations
Overall B factor (Å2) 15.2
0.01
1.22
1Values in parentheses are for the highest resolution shell: 2.59 - 2.5 Å (K42A), 2.23 - 2.15 Å (I87T).
2Rsym = S | Iobs - Iavg | / S Iobs where the summation is over all reflections.
3R-factor = S | Fo - Fc | / S Fo.
4For calculation of Rfree, 4.5% (K42A) and 5.1% (I87T) of the reflections were reserved.
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Isochorismate Preparation 
 Isochorismate was isolated from the CM-deficient Klebsiella pneumoniae 62-1 
harboring the entC plasmind pKS3-02 as described39 with some variations. Plasmid 
pKS3-02 was transformed into K. pneumoniae 62-1 by electroporation. Five ml of an 
overnight culture of K. pneumoniae 62-1/pKS3-02 in Nutrient broth was inoculated 
into 1 L of medium A40 with shaking 250 rpm at 30°C until OD600nm of 1.2 ~ 1.4. The 
cells were harvested by centrifugation (4000 × g, 10 min, 4 °C). The pellet was 
resuspended in 1 L of medium BN39 and shaken at 250 rpm, 30 °C. After 14 ~ 16 h, 
supernatant was collected by centrifugation (4000 × g, 30 min, 4°C). Due to the fast 
decomposition rate at high temperature, all of the following steps were performed at 4 
°C unless stated. The supernatant was titrated to pH 8.0 with 10 M NaOH. The 
supernatant was applied to the Dowex column (1 × 8, 200-400 mesh, Cl-) with tap 
vacuum and washed with H2O. After elution with 1 M NH4Cl pH 8.5 at rate of 
2ml/min, fractions with A280nm above 200 mAU were combined, neutralized using 
HCl, and freeze-dried. The dried powder was extracted 3 times with 50 ml of 
methanol by sonication.  Methanol extracts were pooled and rotary-evaporated. The 
residue was dissolved in 10 ml water.  
 Before large scale separation on HPLC, 20 %l of the sample was tested on an 
analytical HPLC column (Nucleosil 5u C18 100A, 150 × 4.6 mm) with a methanol 
gradient (0-5 min, 0% MeOH; 5-15, 10% MeOH; 15-25 min, 20% MeOH; 25-35 min, 
30% MeOH; 35-48 min, 40% MeOH) as a mobile phase, running at 1 ml/min. The 
column output was recorded at 278 nm. Isochorismate eluted at 17 min with 20% 
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MeOH. Once sample was confirmed to contain isochorismate, a 5 ml sample aliquot 
was applied to a preparative column (Nucleosil 5u C18 100A column, 250 × 21.2 mm) 
in H2O pH 2.5 (titrating with trifluoroacetic acid). A methanol gradient (0-35 min, 0-
10% MeOH; 35-50 min, 10-20% MeOH; 50-85 min, 20-30% MeOH; 85-100 min, 
30-45% MeOH) was used as mobile phase with a flow rate of 10 ml/min. 
Isochorismate eluted with 20.6% MeOH at 52 min. Pooled fractions containing 
isochorismate were neutralized by NaOH, freeze-dried, and stored at -80 °C. The 
concentration of isochorismate was determined by UV spectroscopy using $278 = 8, 
300 M-1 cm-1
. 
1H-NMR spectrum of isochorismate in D2O was recorded on Bruker 
Avance 500 MHz spectrometer.  
 
Steady-State Kinetic Studies  
 The IPL activities of wild type and mutant PchB enzymes were measured in an 
assay buffer 50 mM Na/K phosphate pH 7.5 at room temperature. The reaction 
mixture (final volume 100 %l) contained 1~2 %M enzyme. The isochorismate 
concentration was varied in assays for wild type, I87T, and A43P enzymes (1-80 %M); 
and for K42A, K42H, and K42Q mutants (5-390 %M). Initial velocities were 
determined by measuring the fluorescence of the product salicylate at an excitation 
wavelength of 300 nm and an emission wavelength of 430 nm with a fluorescence 
spectrophotometer (Cary Eclipse, Varian) over 2 min. The amount of salicylate 
formed was determined from a standard curved with varied salicylate concentration 
(0-80 µM) in the reaction buffer. Kinetic constants Vmax, Km and kcat were calculated 
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from Michaelis-Menten equation ('=Vmax[S]/(Km+[S]) using KaleidaGraph. 
 For CM activity, chorismate was recrystallized from 60-80% pure chorismate 
(Sigma) as described previously.41 All steady-state kinetic measurements on CM were 
performed in 50 mM Na/K phosphate pH 7.5 at room temperature. Chorismate 
concentration was varied between 0.1 mM and 1.4 mM. The reaction mixture (final 
volume 100 %l) contained 50~80 %M enzyme. Initial velocities were determined by 
measuring the disappearance of chorismate at 310 nm ($310 = 370 M-1 cm-1)22 on a UV 
spectrophotometer (Cary 50 Bio, Varian). Steady-state kinetic parameters were 
derived from the initial velocities of chorismate disappearance with KaleidaGraph.  
 
Temperature Dependence of PchB Catalyzed Reactions   
 To determine the enthalpy and entropy contributions for both CM and IPL 
reactions performed by PchB, CM and IPL Reactions were conducted at temperatures, 
from 5 °C to 45 °C for IPL, 10 °C to 45 °C for CM, and 25 °C to 60 °C for the 
isochorismate uncatalyzed reactions. Chorismate disappearance and salicylate 
accumulation were monitored as described previously in this chapter for steady-sate 
measurements. kcat was determined using Michaelis-Menten kinetics at each 
temperature. The thermodynamic parameters were obtained from least-squares 
analysis of the collected data using the Eyring equation:42  
kcat = (kT/h) e - [(!H‡/RT) - (!S‡/R)] 
where k = Boltzmann’s constant, h = Planck’s constant, R = ideal gas constant, and T 
= absolute temperature. All data analysis was performed with KaleidaGraph. 
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2.3 Results 
Enzyme Production 
 The mutant enzymes were generated from pET29b-pchB and purified in yields 
of 175 to 250 mg per liter cell culture using an anion exchange followed by a size 
exclusion chromatography. All mutant enzymes eluted as a homodimer (~ 23 kDa) 
from size exclusion column as wild type enzymes. The purities of enzymes were 
~99% as determined by SDS-PAGE (data not shown). 
 
CD Spectra Measurements 
 To investigate effects of single mutation on the overall secondary structure of 
PchB, the CD spectra of mutant enzymes were recorded and shown in Figure 2-4. 
Spectra of all mutants and the wild type  display maximum near 190 nm and minina 
at 208 nm and 222 nm, consistent with the characteristics of !-helical folding. 
Mutations at position 42 and 43 do not show a shoulder at ~ 210 nm in our CD 
spectra as the EcCM mutants did.19 
 
PchB K42A and I87T Structures 
 The crystals of K42A and I87T belong to the space group P212121. The 
structures were determined by molecular replacement using wild type pyruvate bound 
(PDB code 2H9D)4 as a model with omission of waters and ions. 
 The K42A structure was determined to 2.5 Å with salicylate and pyruvate 
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Figure 2-4: Overlay of the circular dichroism spectra of wild type and 
mutant PchB enzymes. Spectra were acquired for all the mutants and wild 
type enzymes studied. The spectra shown are the average of five scans, 
corrected for buffer blank and smoothed. The resulting spectra of mutants 
are very similar to that of the wild type PchB. 
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bound in the active site. Each asymmetric unit for K42A crystal contains one 
homodimer formed from two intertwined monomers (A and B).  Both monomer A 
and B comprise residues 1 – 99. Two residues are disordered at the C termini of both 
monomers. The K42A structure is summarized in Table 2-2. The dimer has two 
closed active sites, and each contains one salicylate and one pyruvate. Salicylate 
binds more deeply in the active site, which is consistent with the prediction using 
wrong-ligand crystallographic refinement modeling.4 The carboxylate group in 
salicylate is oriented by the side chain Arg31, and the pyruvate is oriented by Arg14 
in the active site. The K42A structure is overlayed with wild type, and Figure 2-5a 
shows the superposition of the active sites. The overall root mean square deviation 
(RMSD) for the K42A monomer shown is 0.43 Å for 98 C# positions, and for the 
dimer is 0.58 Å for 197 C# atoms. These comparisons demonstrate that the integrity 
of the three-dimensional structure is well maintained after the mutation, which is also 
supported by the CD spectrum. The active site of K42A is conserved with RMSD of 
0.21 Å for the C# (position 42) in the shown monomer, and 0.46 Å for that in the 
opposing monomer. An electron density map for the active site can be found in 
Figure 2-5b.   
 The I87T structure was determined to 2.15 Å. The asymmetric unit contains 2 
dimers. There are more disordered regions in I87T structure as compared to wild type. 
As summarized in Table 2-2, no electron density was observed in the regions between 
helices 1 and 2 from amino acid 44 to 55 in monomer A, 42 to 50 in monomer B, 40 
to 53 in monomer C. One to nine amino acids at the N termini and three to eight 
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Table 2-2: Summary of K42A and I87T structures
Ordered amino acids Ions in active site
K42A
Monomer A 1-99 salicylate and pyruvate
Monomer B 1-99 salicylate and pyruvate
I87T
Monomer A 2-43, 56-94 none
Monomer B 10-41, 51-93 none
Monomer C 2-39, 54-98 none
Monomer D 2-98 none
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Figure 2-5: PchB K42A structure. a. Superposition of 
K42A (light purple) and pyruvate-bound closed wild 
type PchB (yellow; PDB code 2H9D) active sites. The 
salicylate and pyruvate molecules of the K42A structure 
are green sticks, and two pyruvates of the wild type 
structure are yellow sticks. b. An electron density map 
of the K42A active site. Figures were generated in 
PyMOL. 
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amino acids at C termini are disordered as well. The superposition of two I87T 
dimers from each asymmetric unit and the wild type structure is shown in Figure 2-6a. 
When ligands are not present in the active site, the mobile loops between the first two 
helices in monomer A, B and C have poorly defined structure. The disordered regions 
extended to several amino acids of helix 2 in A and C monomers. The electron 
density map of one active site is shown in Figure 2-6b. These unstructured regions 
may become ordered upon substrate binding. 
 
Isochorismate Preparation 
 Isochorismate was isolated from K. pneumoniae 62-1/pKS3-02. The final 
purifying step was performed on HPLC system using methanol gradient as a mobile 
phase. A pre-run of sample was done on a small analytical HPLC C18 reverse phase 
column. The isochorismate eluted with 20% methanol at ~17 min followed by the 
chorismate peak at ~20 min (Figure 2-7a). A larger column was used for preparation 
of bulk isochorismate. Two peaks (52 min and 65 min) of 20-30% methanol from the 
preparative HPLC column (data not shown) were collected, acidified, and freeze-
dried. Small amount of dried powder of two peaks were dissolved in D2O, and 1H 
NMR spectra were recorded. The spectrum for the 52 min peak (Figure 2-7b) matches 
the published data for isochorismate.43 Due to the fast rate of uncatalyzed 
decomposition, the isochorismate sample in water was aliquoted and stored at – 80 °C. 
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Figure 2-6: PchB I87T structure. a. Superposition of I87T 
two dimers (A and B in green, C and D in deep blue) from 
an asymmetric unit and the wild type pyruvate-bound 
closed structure (purple ribbon). d. An electron density 
map of the I87T active site with ordered Lys42 . Figures 
were generated in PyMOL. 
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Figure 2-7: Separation of isochorismate. a. RP-HPLC analysis of the dried 
methanol extract that was dissolved in water. Isochorismate eluted at 20% 
methanol with retension time of 17 min followed by chorismate with retension 
time of 21 min, which was comparable to that described.39 b. 1H-NMR spectrum 
of the isochorismate peak from HPLC. Peaks for isochorismate are indicated by 
asterisks. 
a.
b. 
* 
* * 
* 
* 
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Determination of Steady-State Kinetic Parameters   
 To gain insight into the PchB reaction mechanisms, six mutants that differed 
from the wild type PchB by a single amino acid substitution were constructed and 
purified: K42A, K42E, K42Q, K42H, A43P, and I87T. Both CM and IPL activities 
were measured for wild type and each mutant. The steady-state kinetic parameters are 
summarized in Table 2-3a for CM, and 2-3b for IPL activities. Wild type PchB 
catalyzes CM reaction with kcat of 1.41 min-1 and Km of 120 %M, and IPL reaction 
with kcat of 10.6 min-1 and Km of 4.3 %M.  
 Both CM and IPL activities were detectable for all mutants except K42E and 
K42Q. Mutant K42E has no measurable CM or IPL activities, and K42Q has no CM 
activity but remains some IPL activity. Lys42 in the mobile loop is within 
electrostatic and H-bonding distance of the ether oxygen (O7) of substrate, and has 
been proposed to play a critical catalytic role.4 Removal of both positive charge and 
hydrogen bonds at position 42 through K42A leads to approximately 100-fold 
reduction in kcat/Km for both CM and IPL activities. Removal of positive charge with 
hydrogen bonds intact through K42Q and K42H mutants results in a decrease in 
kcat/Km by ~ 60-fold for IPL reaction. K42H retains 3% catalytic efficiency on CM 
activities probably due to the partial protonation of the imidazole ring of histidine at 
pH 7.5, which results in little effect on kcat but ~ 30-fold increase in Km relative to 
wild type PchB. These large reduction in catalytic efficiency associated with 
mutations at Lys42 indicates that the electrostatic and hydrogen bonding abilities at 
site 42 are critical to both the kcat and Km of CM and IPL.  
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Enzymes Km (!M) kcat (min-1) kcat / Km (M-1s-1) 
% wild type 
(kcat / Km) 
Wild type 120 ± 10 1.41 ± 0.03 201 100 
K42A 720 ± 30 0.09 ± 0.00 2 1 
K42E * * - - 
K42Q * * - - 
K42H 3770 ± 40 1.61 ± 0.02 7 3 
A43P 186 ± 2 1.57 ± 0.01 141 70 
I87T 440 ± 20 4.09 ± 0.07 155 77 
 
 
 
 
 
  
Enzymes Km (!M) kcat (min-1) kcat / Km (M-1s-1) 
% wild type 
(kcat / Km) 
Wild type 4.3 ± 0.2 10.6 ± 0.1 41200 100 
K42A 51 ± 3 1.47 ± 0.03 480 1 
K42E * * - - 
K42Q 66 ± 3 2.81 ± 0.05 714 2 
K42H 57 ± 2 2.22 ± 0.04 640 2 
A43P 5.3 ± 0.1 11.3 ± 0.3 36700 89 
I87T 1.09 ± 0.05 0.85 ± 0.02 13000 32 
 
 
 
 
 
 
 
 
 
Table 2-3b: Comparison of steady-state kinetic parameters of isochorismate-
pyruvate lyase activities of wild type and mutant PchB 
Table 2-3a: Comparison of steady-state kinetic parameters of chorismate mutase  
activities of wild type and mutant PchB 
* = below the limits of detection, 0.3 pmol for IPL assay 
 
* = below the limits of detection, 0.8 nmol for CM assay 
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 A43P mutant was designed to increase rigidity of the active site loop, which 
might suggest the overall contributions of active site loop motility to catalytic 
efficiencies. A43P has a kcat/Km of 70% of the wild type CM activity, and 89% of the 
wild type IPL activity. Two activities are covariant, with a slightly faster turnover rate 
(kcat) and lower substrate binding affinity (Km), which needs to be deconvoluted with 
the transient kinetics in the future. 
 The I87T mutant was previously identified as a mutation that was IPL defective 
but CM competent in PchB.2 However, in our hands the I87T mutant has a catalytic 
efficiency (kcat/Km) of 32% of the wild type IPL activity, and 77% of the wild type 
CM activity.  
 
Determination of the Activation Parameters 
 Tables 2-4 and 2-5 summarize the thermodynamic activation parameters 
calculated from the observed effects of temperature on the PchB catalyzed 
intramolecular rearrangements. The activation parameters for CM and IPL were 
determined by measuring the reaction rates of enzyme-catalyzed reaction in a 
temperature range of 10 to 45 °C for CM, and 5 to 45 °C for IPL. The rate constant of 
spontaneous rearrangement of isochorismate to salicylate was determined from 25 °C 
to 60 °C. Values for the enthalpy and entropy of activation (!H‡ and !S‡) were 
obtained by fitting rate constant versus temperature in to Eyring equation. Those 
resulting linear plots are shown in Figures 2-8 and 2-9. The enthalpy and entropy of 
activation for kcat were found to be 15.9 kcal·mol-1 and -12.1 cal·mol-1K-1 in PchB CM  
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chorismate mutase !G
‡ 
(kcal·mol-1) 
!H‡ 
(kcal·mol-1) 
!S‡ 
(cal·mol-1·K-1) 
T!S‡ 
(kcal·mol-1) 
Uncatalyzed rearrangementa 24.5 20.7 -12.8 -3.8 
PchB CM 19.5 15.9 -12.1 -3.6 
KpCMb 
Klebsiella pneumoniae 16.2 15.9 -1.1 -0.3 
BsCMc 
Bacillus subtilis 15.4 12.7 -9.1 -2.7 
SaCMb 
Streptomyces aureofaciens 15 14.5 -1.6 -0.5 
!G‡ was calculated for 25 °C, T = 298.15 K 
aAndrews, P.R., et al, Biochemistry 12, 3492-98 (1973). 
bGorisch, H., Biochemistry  17, 3700-05 (1978). 
cKast, P., et al, Tetr Lett 37, 2691-94 (1996). 
 
 
Table 2-4:  Activation parameters of the chorismate mutase reaction 
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Figure 2-8:  Temperature dependence of kcat for 
chorismate mutase activity of PchB. 
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Isochorismate-pyruvate 
lyase 
!G‡ 
(kcal·mol-1) 
!H‡ 
(kcal·mol-1) 
!S‡ 
(cal·mol-1·K-1) 
T!S‡ 
(kcal·mol-1) 
Uncatalyzed rearrangement 25.5 21.4 -13.8 -4.1 
PchB IPL 18.5 11.1 -24.8 -7.4 
!G‡ was calculated for 25 °C, T = 298.15 K 
 
Table 2-5:  Activation parameters of the isochorismate-pyruvate lyase reaction 
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Figure 2-9. Temperature dependence of reaction rate for isochorismate 
rearrangement to salicylate. a. Uncatalyzed reaction in solution, b. Reaction 
catalyzed by PchB IPL activity. 
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activity, 11.1 kcal·mol-1 and -24.8 cal·mol-1K-1in PchB IPL activity. The activation 
free energy !G‡ is 19.5 kcal mol-1 with the activation enthalpy (!H‡) of 15.9 kcal mol-
1
 in PchB CM catalysis, which is lower than that found for uncatalyzed reaction in 
solution (!G‡ is 24.5 kcal mol-1, !H‡ is 20.7 kcal mol-1). This accounts for a rate 
acceleration of at least 103-fold by PchB CM (!!G‡ = 5 kcal mol-1), which indicates 
that PchB is a less optimized for CM activity compared to most chorismate mutases30 
as the three described in Table 2-4 have !!G‡ in range of 8 ~ 9.5 kcal mol-1. PchB 
has almost the same activation entropy (!S‡ = -12.1 cal mol-1K-1) as the uncatalyzed 
rearrangement in solution (!S‡ = -12.9 cal mol-1K-1) and is less favorable than CMs 
from K. pneumonia (KpCM) and S. aureofaciens (SaCM). Similar values of the 
entropic terms (-T!!S‡) was reported as 0.3 kcal mol-1 for KpCM and 0.5 kcal mol-1 
for SaCM, in which their contributions to !!G‡ are 44% and 35%, for KpCM and 
SaCM catalyzed reactions, respectively. Whereas, PchB CM is more related to BsCM 
from the thermodynamic point of view. PchB has -T!!S‡ of 0.2 kcal mol-1, and 
BsCM has 1.1 kcal mol-1. The difference between !G‡cat and !G‡uncat (!!G‡) 
predominately arises from a difference in activation enthalpies (!!H‡). 
 
2.4 Discussion 
 Chorismate mutase catalyses the [3,3]-Claisen rearrangement of chorismate to 
prephenate, the committed step in the biosynthesis of aromatic amino acids in 
microoganisms.44 Because the chorismate rearrangement is not involved in covalent 
bonding with enzyme groups, CMs have been used as a model system to study 
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enzyme energetics for decades, but the source of catalytic power of these enzymes is 
still the subject of controversy. The two proposals gained the most attention: 
electrostatic transition state stabilization (TSS) and generation of a reactive substrate 
conformation. The electrostatic TSS proposal states that the charged/polar amino acid 
side chains in the active site are positioned precisely such that the active site 
preferentially binds the transition state over the ground state and stabilizes the 
developing negative charge in the TS, thus lowering the activation energy barrier. The 
reactive substrate conformation referred as a near attach conformation (NAC) by Hur 
and Bruice,29 believes that the CM help in bringing the reacting atoms of chorismate 
to form a  reactive substrate conformer - NAC, and once chorismate achieves this 
conformation the arrangement can proceed without addition of TSS. 
 PchB, a bifunctional enzyme in P. aeruginosa, has a physiological role as an 
isochorismate-pyruvate lyase and possesses weak chorismate mutase activity. PchB 
does not apply a general base mechanism to eliminate the pyruvate side chain from 
isochorismate as pyruvate lyases of other shikimic acid metabolites do.45-47 Instead, 
the IPL activity of PchB uses a [1,5]-sigmatropic rearrangement mechanism.5 
Therefore, there are two pericyclic reactions that can happen in PchB active site, 
which indicates that during catalysis two NACs (Figure 2-3) will be formed, followed 
by formation of two transition states. Compared to the active sites of EcCM and 
BsCM (Figure 2-2), PchB active site has fewer charged/polar amino acids, which led 
to a hypothesis that the reduced electrostatic and hydrogen bonding interactions with 
substrate in PchB may provide this single active site with the ability to catalyze both 
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CM and IPL reactions.4 Structures of apo- and pyruvate – bound PchB suggested that 
Lys42 and Gln90 might have stabilization effects on transition states. Lys42, the only 
active site amino acid found in a mobile loop, becomes ordered upon substrate 
binding,4 which acts as a portal that helps with arranging the enolpyruvate side chains 
of substrates to form NACs, leading to aromatization in chorismate or pyruvate 
elimination from isochorismate. In this chapter, several single mutations on Lys42 
were tested to explore the relative contributions of TSS and NAC for CM and IPL 
catalysis. The CD spectra of mutants and wild type PchB were comparable (Figure 2-
4), which indicates that the structural integrity was well-maintained in each mutant. 
The x-ray crystallographic structure of K42A exhibited an intact active site 
architecture including an ordered active site loop and salicylate and pyruvate bound 
within the active site (Figure 2-5a and b). Therefore, variation in steady-state kinetic 
parameters of mutants is completely due to the modification of a single amino acid 
side chain without alteration of the active site.  
 CM activity of PchB and mutant enzymes was determined by spectrometrically 
measuring the disappearance of chorismate.22 Reverse of charge at position 42 
through K42E leads to no measurable CM activity, indicating that the negatively 
charged Glu42 may interrupt the shuttle of chorismate into the active site by repulsion 
of the C11 carboxylate group on chorismate, such that the enolpyruvate side chain 
can not be properly positioned over the cyclohexadiene ring to form a reactive 
pseudo-diaxial conformation and adopt the TS. Mutant K42A differed from wild type 
enzyme in its aliphatic side chain without charge or H-bonding ability. However, 
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K42A still has 1% of the wild type CM activity. An explanation for this 1% of 
residual activity is due to a contribution from NAC formation in the active site, since 
the active site of K42A still provides a shape in complementary to NAC. K42Q is a 
mutant with a neutural polar side chain and has no detectable CM activity, suggesting 
that the H-bonding ability of Gln42 was not enough for catalysis. Taking K42A into 
consideration, a possible reason is that H-bonding of Gln42 with the nearby Gln90 via 
a water molecule may alter the orientation of these two important residues relative to 
chorismate in a way that K42Q active site cannot provide the proper shape for NAC. 
Replacement of Lys42 by histidine with a titrable imidazole group on the side chain 
remains 3% of the catalytic efficiency, which results from ~ 5% of imidazole group 
was protonated at pH 7.5 (the reaction buffer) given that a calculated pKa of 6.2 for 
the active site histine.48 K42H has a little increase in kcat (~ 1.2-fold) but leads to 32-
fold increase in Km. Therefore, a positive charge at position 42 is critical for CM 
catalytic efficiency, indicating that electrostatic TSS is critical for the CM activity. 
This conclusion can find the support in the pH dependence of K42H experiment that 
the CM activity in K42H was not detectable at pH values above 7.5.48 
 The IPL activities of PchB and mutants were determined by measuring the 
formation of product salicylate using fluorescence.2 For each mutant, the IPL activity 
remains dominant over the corresponding CM activity. The IPL and CM activities of 
K42A and K42H are covariant, giving a kcat/Km of 1% and 2% of wild type IPL 
activity, respectively. The CM-deficient mutant K42Q has 2% of IPL activity relative 
to wild type, suggesting that substrate isochorismate probably is aligned in a different 
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way due to the relocation of a hydroxyl group from C4 to C2. This residual IPL 
activity results from NAC of isochorismate in K42Q active site.  
 The A43P mutant was designed to increase the rigidity of the active site loop by 
replacing an alaine with a bulky residue proline at position 43. A43P results in a 1.5-
fold and a 1.2-fold reduction in kcat/Km relative to wild type CM and IPL, respectively. 
Both CM and IPL have a slightl increase in kcat and Km. The relationship of the active 
site loop and catalytic activity will be determined using transverse relaxation 
optimized NMR approach in the future by the next graduate student. 
 I87T was originally reported by Gaille et al. (2002) to be an IPL deficient and 
CM competent enzyme. However, according to our kinetic data, I87T has not 
completely lost IPL activity, but retains 32% of kcat/Km from wild type. Differences in 
the protein overproduction system and the sensitivity of the assay measurement 
probably count for the variation in kinetic observations, which Gaille group 
overexpressed I87T in E. coli and measured salicylate fluorescence in ethyl acetate 
after the reaction was stopped by concentrated HCl.2 The structure of I87T displays 
more disordered regions compared to wild type pyruvate-bound closed structure 
(Figure2-6). This intrinsic disorder in the enzyme may play an important role in 
catalysis.49  
 Enzymes achieve rate enhancement by lowering the activation energy (!G‡) 
compared to the uncatalyzed reaction in solution.50 !G‡ is given by 
!G‡ = !H‡ - T!S‡ 
Activation enthalpy !H‡ is the difference between the transition state enthalpy and 
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the sum of reactants enthalpies in the ground state, representing the extent of bond-
breaking and bond-making in the transition state. Activation entropy !S‡ is the 
difference between the transition state entropy and the sum of the entropies in ground 
state reactants, which indicates the conformational change as the system progressing 
to the transition state. In order to achieve efficient catalysis, enzymes may increase 
the entropic term (T!S‡) of !G‡ by reducing the degree of freedom, or control the 
preorganization state in the active site for formation of ground state NACs.51 
 The rate enhancement of enzyme results from reduction in the activation 
enthalpy and/or the activation entropy.11 Entropies of activation !S‡ in PchB CM and 
BsCM are very similar to that in water, therefore the overall catalysis is due to 
enthalpic effects. In KpCM and SaCM, catalysis are dependent on both enthalpy and 
entropy, given that 44% and 35% of entropic contributions to catalysis, which 
supports the idea that enzyme catalysis arises from entropy loss upon substrate 
binding.52 However, Warshel et al.53 have shown that the binding of substrate to 
enzyme does not lead to loss of many degrees of freedom compared to the substrate 
in solution. One can suppose that the driving force for the rate enhancement of PchB 
CM is enthalpic. PchB preorganizes the active site for NAC and TS, lowering the free 
energy of the TS by electrostatic interactions to achieve the most catalytic efficiency.
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CHAPTER 3 
 
Salicylate Synthetic Enzymes in Pseudomonas aeruginosa  
and Yersinia enterocolitica 
 
3.1 Introduction 
 Chorismate, the final product of the shikimate pathway, is a precursor for 
aromatic amino acids, vitamins K and E, menaquinones, siderophores and other 
metabolites in bacteria.1 There are three important chorismate-utilizing enzymes that 
catalyze 1) isomerization of chorismate to isochorismate (isochorismate synthase, 
ICS), 2) replacement of the hydroxyl group at C4-chorismate by an amine 
(aminodeoxychorismate synthase, ADCS), or 3) removal of the C4 hydroxyl group 
followed by addition of amine at C2-chorismate (anthranilate synthase, AS). These 
enzymes are involved in the first committed step of menaquinone, siderophore, or 
tryptophan biosynthesis, so they are referred as MST family.2 MST enzymes share 
high sequence homology and most MST members3-6 are structurally homologous,  
and have a similar catalytic mechanism.1 The absence of chorismate-dependent 
pathways in mammals makes chorismate-utilizing enzymes attractive targets for 
antimicrobial treatments for bacterial infections. 
 Derived from chorismate, isochorismate is an important intermediate of 
siderophore and menaquinone production in bacteria. Enzymes that catalyze these 
conversions belong to the Mg2+-dependent MST family. Shown in Figure 3-1 are the 
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Figure 3-1: Conversion of chorismate to isochorismate and its incorporation into 
siderophores or menaquinone. Formation of isochorismate is the first committed step 
in formation of siderophores (pyochelin, mycobactin, yersiniabactin, and 
enterobactin) and menaquinone (vitamin K). 
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reactions of the most studied ICS enzymes including PchA in P. aeruginosa,7 MbtI in 
M. tuberculosis,5 Irp9 in Y. enterocolitica,8 MenF and EntC in E. coli9. PchA, EntC 
and MenF are monofunctional ICS, whereas Irp9 and MbtI are salicylate synthases 
that perform a second reaction in which the pyruvate is eliminated from isochorismate 
to produce salicylate. In other words, in order for P. aeruginosa to utilize salicylate as 
a building block for siderophore pyochelin biosynthesis, a second enzyme (PchB) is 
required to remove the pyruvate tail from isochorismate (IPL activity) made by PchA 
to generate a salicylate.10 It would be quite interesting to biochemically and 
structurally characterize the ICS PchA that will provide insight into the enzyme 
evolution in MST family and the search for inhibitors of salicylate synthesis.  
 EntC and MenF are two ICS in E. coli that catalyze an identical reaction, but 
their expression is regulated under different growth conditions, and are involved in 
different metabolism pathways. EntC is responsible for making isochorismate that is 
required for siderophore enterobactin biosynthesis under iron deficiency in E. coli, 
while MenF produces isochorismate for menaquinone synthesis under anaerobic 
conditions, which is essential for electron transport and ATP synthesis in E. coli.11 
PchA is 25% identical and 42% similar to EntC, and 34% identical and 50% similar 
to MenF (sequence alignment was performed in ClustalW12). The x-ray 
crystallographic structure of MenF has been determined,2,6 which has an #/" overall 
fold (Figure 3-2a) similar to other chorismate-utilizing enzyme, such as anthranilate 
synthase in Serratia marcescens3. The MenF active site contains a sulfate ion that 
occupies the place where chorismate would bind and a magnesium ion that interacts 
 78 
 
 
 
 
Figure 3-2: MenF overall and active site structures. a. 
Overall structure. MenF exhibits an !/" fold with 
antiparellel "-strands rapped around by !-helices.  b. 
MenF active site structure. Sulfate ion is yellow stick and 
magnesium ion is purple sphere. Three important water 
molecules were found in the MenF active site, two 
involved in Mg2+ chelating and one is hypothesized to act 
as a nucleophile to attach C2-chorismate after activation 
by K190. Figures were created using PyMOL. (PDB ID 
3BZN) 
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with the C1 carboxylate of chorismate (Figure 3-2b)2. Kolappan et al.2 proposed the 
mechanism through which MenF rearranges chorismate to isochorismate (Figure 3-3). 
In the active site, Mg2+ is coordinated by two acidic residues E284 and E416 which in 
turn orients the C1 carboxylate group of chorismate. In contrast to anthranilate 
synthase, Mg2+ ion is not directly involved in catalysis.1 The reaction starts with the 
activation of a water molecule by K190. The activated water acts as a nucleophile to 
attack the chorismate at the C2 carbon resulting in the SN2( rearrangement of 1-2 and 
5-6 double bonds followed by elimination of the C4 hydroxyl group. E240 is in the 
proximity of C4-OH and thus expected to serve as a general acid to promote 
departure of the C4-OH.2  
 In contrast to P. aeruginosa which requires PchA and PchB to make salicylate, 
in some bacteria, the salicylate is generated from chorismate in a single step catalyzed 
by the bifunctional enzyme salicylate synthase, including Irp9 in Y. enterocolitica and 
MbtI in M. tuberculosis.5,8 PchA shares 28% identity and 47% similarity to Irp9, and 
30% identity and 47% similarity to MbtI, whereas PchB has no sequence similarity to 
these two enzymes. Studies have demonstrated that Irp9 and MbtI are bifunctional 
salicylate synthases with both isochorismate synthase and isochorismate-pyruvate 
synthase activities, and that isochorismate is a detectable intermediate during the 
catalysis.4,5,8,13 Both Irp9 (Figure 3-4a) and MbtI x-ray crystallographic structures 
have the same fold as that previously described for MenF. The Irp9 active site with 
salicylate and pyruvate bound is shown in Figure 3-4a. Mg2+ coordinates with Glu 
directly or through a water molecule, and the salicylate carboxylate. The role of a 
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Figure 3-3: General acid and base catalysis 
proposed by MenF. (Modified from Kolappan et 
al. 2007) 
 81 
 
 
 
Figure 3-4: Salicylate synthase Irp9. a. Overall structure of Irp9. 
Irp9 is a dimeric Mg2+-dependent salicylate synthase and has a 
!/" fold similar to MenF. b. The active site of Irp9 with 
salicylate and pyruvate bound. The corresponding amino acid 
residues in PchA are shown in parenthesis. (PDB code 2FN1). 
Figures were created with PyMOL. 
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divalent cation in the active site of salicylate synthase is proposed to orient the 
carboxylate on C1 chorismate without direct involvement in catalysis.2,4   
 According to structural and mechanistic studies on ICS and salicylate synthase 
in conjunction with sequence analysis (Figure 3-5 and Table 3-1), a reaction 
mechanism for MST family has been proposed13 which can extend to PchA. It is 
proposed that nucleophilic addition of water to C2 promotes departure of C4-OH 
from chorismate. As shown in Figure 3-5, the active site residues of five displayed 
enzymes are highly conserved except for two (labeled with asterisks). The first 
nonconserved residue is Ala (A375 in PchA) that is conserved in ICS but is 
substituted by Thr in salicylate synthase, which might result in the loss of capability 
to eliminate enolpyruvate from isochorismate (IPL-deficient) in the ICS. The H-
bonding of the backbone carbonyl of T348 to hydroxyl group of salicylate in Irp9 
(Figure 3-4b)4 may be shift compared to Ala, which was hypothesized to be critical 
for the IPL activity through alignment of isochorismate in the active site for the IPL 
reaction. The second nonconserved residue is Asp/Asn (D310 in PchA) in ICS but 
Glu in salicylate synthase. The role of this Glu in salicylate synthase is to coordinate 
Mg2+ through H2O. The replacement of Glu by Asp/Asn with a shorter side chain 
might lead to a change in isochorismate orientation through pulling Mg2+ more deep 
in the active site, which may control the retention of the enolpyruvate on 
isochorismate. 
 To test these hypotheses, four active site mutations were constructed and 
kinetically analyzed in this chapter. Crystallization trials of PchA and Irp9 were 
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Figure 3-5: Active site sequence alignment of five chorismate-utilizing enzymes 
from MST family.  Important residues are highlighted in colors. Residues K (red) and 
E (blue) were found to be general base and general acid in MenF and conserved in all 
aligned enzymes. Residues (E in green) coordinating Mg2+ are highly conserved. 
Backbone carbonyl of T (orange) H-bonds to hydroxyl group in salicylate. Y and R 
(in purple) orient carbonyl group in pyruvate. Sequence alignment was performed 
with ClustalW. Residues selected were based on MenF (PDB code 3BZN), Irp9 (PDB 
code 2FN0 and 2FN1), and MbtI (PDB code 2I6Y) active site structures.  
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Isochorismate Synthase  Salicylate Synthase 
 
PchA 
(P. aeruginosa) 
MenF 
(E. coli) 
 
 
Irp9 
(Y. enterocolitica) 
MbtI 
(M. tuberculosis) 
General base for 
ICS activity K221 K190  K193 K205 
General acid for 
ICS activity E269 E240  E240 E252 
Coordinate Mg2+ 
ion through H2O 
D310 
E445 
N281 
E413  
E281 
E417 
E294 
E431 
Coordinate Mg2+ 
ion 
E313 
E448 
E284 
E416  
E284 
E420 
E313 
E434 
Orient pyruvate Y399 R419 
Y368 
R387  
Y372 
R391 
Y385 
R405 
Orient salicylate 
hydroxyl group A375 A344  T348 T361 
Table 3-1: Comparison of active site amino acids of PchA and its homologues 
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carried out in an attempt to obtain structural information that will help with 
elucidation of PchA reaction mechanism and rational design of inhibitor of salicylate 
biosynthesis, and hence development of treatments for P. aeruginosa, Yersinia sp. 
and M. tuberculosis infections. 
  
3.2 Material and Methods 
3.2.1 Protein Production and Characterization 
Cloning of pchA and irp9  
pchA Constructs  
 pchA gene was amplified from P. aeruginosa PAO1 genomic DNA using PCR 
with Herculase polymerase (Statagene). The primers, restriction enzymes, and vectors 
used for each clone are summarized in Table 3-2. The amplified PCR fragments were 
digested with corresponding restriction enzymes, and inserted into selected vectors 
(Novagen). The insert was confirmed by nucleotide sequence analysis. The resulting 
plasmid was transformed into BL21 (DE3) E. coli competent cells (Novagen) for 
protein overproduction later. 
 
Site-directed Mutagenesis  
 Mutation was introduced into  pET28b-pchA construct using the QuikChange 
site-directed mutagenesis kit (Stratagene). Two complementary primers with a single 
mutation was used for each mutant (Table 3-2). The mutation was confirmed with 
DNA sequence analysis. The resultant plasmid was transformed into BL21 (DE3) 
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Protein Primer Primer sequence Restriction 
Enzyme
Plasmid
forward  5’-AAT TAT ATA CAT ATG AGC CGG CTG GCG CCC CTG-3’ NdeI
reverse 5’-ATA ATA CAG ATC TGG GGC GAC GCC GCG CTG CAA GG-3’ BglII
pchA -forward 5'-GGA ATT CGA TGA GCC GGC TGG CGC CCC TG-3' EcoRI
pchA -reverse 5'-CCC AAG CTT TCA GGC GAC GCC GCG CTG-3' HindIII
pchB -forward  5'-GGG AAT TCC ATA TGA AAA CTC CCG AAG ACT GC-3' NdeI
pchB -reverse 5'-GAA GAT CTT CAT GCG GCA CCC CGT GTC-3' BglII
pchB -forward  5'-CAT GCC ATG GGC AAA ACT CCC GAA GAC TGC ACC-3' NcoI
pchB -reverse 5'-ACG CGT CGA CTC ATG CGG CAC CCC GTG TC-3' SalI
pchA -forward 5'-GGA ATT CCA TAT GAG CCG GCT GGC GCC CCT GA-3' NdeI
pchA -reverse 5'-AAA ACT CGA GTC AGG CGA CGC CGC GCT GCA-3' XhoI
forward  5’-AAT TAT ATA CAT ATG AGC CGG CTG GCG CCC CTG-3’ NdeI
reverse 5'-CCC AAG CTT TCA GGC GAC GCC GCG CTG-3' HindIII
forward  5'-GGA ATT CCA TAT GCA CGC CTT GCG CGG CAC C-3' NdeI
reverse 5'-AAA ACT CGA GTC TAT GAG CTT CCC GCA TGG CAC-3' XhoI
forward  5’-GGA ATT CCA TAT GAA AAT CAG TGA ATT TCT ACA C-3’ NdeI
reverse 5’-AAA ACT CGA GCA CCA TTA AAT AGG GCG CAA TG-3’ XhoI
forward  5'-GGG ACG CTT CGG CGC GGT CGT GCT GGC-3'
reverse 5'-GCC AGC ACG ACC GCG CCG AAG CGT CCC-3'
forward  5'-GCG CCT CCC CGG CAC GCC GCC TCC G-3'
reverse 5'-CGG ACC AGG CGT GCC GGG GAG GCG C-3'
forward  5'-GAC AGC GCC AAG GAG AGG CAC GAA CAC C-3'
reverse 5'-GGT GTT CGT GCC TCT CCT TGG CGC TGT C-3'
forward  5'-GCA TCC GAC CCC CAC GGT GGG CGG CTA CC-3'
reverse 5'-GGT AGC CGC CCA CCG TGG GGG TCG GAT GC-3'
¹pETDuet-1 vector contains two multiple cloning sites (MCS). pchA and pchB were insterted into MCS1 and MCS2, respectively.
²pchA  and pchB  were insterted into MCS2 and MCS1, respectively
n.a.= not applicable
PchA D310E
PchA
PchA
PchB/PchA
PchA/PchB
PchAt
Restriction sites are highlighted in red; Mutated codon are highlighted in green.
pET29b
n.a.
n.a.
n.a.
n.a.
pET28b
pET29b
pET28b-pchA
Irp9
Table 3-2: Primers for cloning and mutagenesis
pET28b-pchA
pET28b-pchA
pET28b-pchA
pETDuet-1¹
pETDuet-1²
pET28b
PchA A375T
PchA K221A
PchA E269A
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 E. coli competent cells for protein overexpression. 
 
irp9 Construct  
 irp9 gene was amplified by PCR from Y. enterocolitica (ATCC 9610) genomic 
DNA with the primer pair indicated (Table 3-2) and MasterMix (Eppendorf) with 
addition of 1.5 mM magnesium acetate solution provided. The amplified fragment 
was digested with XhoI/NdeI and ligated into the pET29b plasmid (Novagen). The 
desired plasmid encoded Irp9 (pET29b-irp9) with a C-terminal His6 tag was 
confirmed by sequence analysis.  This overexpression vector was then transformed 
into BL21 (DE3) E. coli cells for protein overproduction.          
  
 
Protein Overexpression and Purification 
C-terminal His6-tag PchA   
 E. coli BL21 (DE3) cells harboring the pET29b-pchA construct were grown in 
Terrific Broth (TB) with 1% (v/v) glycerol and 50 %g/ml kanamycin at 37 °C, shaking 
at 225 × rpm. When the OD600 reached 0.6, the temperature was lowered to 18 °C for 
30 min before induction. Protein expression was induced with the addition of IPTG to 
a final concentration of 0.2 mM.  Incubation at 18 °C was continued for another 14 ~ 
16 h. Cells were harvested by centrifugation (4,000 × g for 10 min at 4 °C) and 
resuspended in 25 mM Tris-HCl, pH 8.0, 500 mM NaCl (buffer A). The cells were 
disrupted by passing them through a French Press cell (35,000 psi) three times, and 
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cell debris was pelleted by centrifugation at 15,000 × g for 30 min at 4 °C. All of the 
following purification steps were performed at 4 °C. The lysate was applied to a 
chelating Sepharose Fast Flow column (Amersham) charged with Ni2+ and 
equilibrated with buffer A.  PchA elution was carried out with a linear gradient of 5 
mM – 300 mM imidazole in buffer A. Fractions containing PchA were combined and 
dialyzed against buffer 50 mM Tris-HCl pH 9.5, 1 mM EDTA, 10% glycerol (buffer 
B) overnight, which was followed by purification on Source 30Q (GE Healthcare) 
anion exchange chromatography. PchA eluted with a linear 0 – 500 mM NaCl 
gradient in buffer B. PchA fractions were identified by SDS-PAGE, pooled, 
concentrated, and further purified by a gel filtration column (HiLoad 16/60 Superdex 
200) in 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1mM DTT, 10% glycerol. The 
eluant peaks were analyzed on SDS-PAGE and PchA peak (52kDa) was pooled, 
concentrated, and stored at – 80 °C for future use. 
 
N-terminal His6-tag PchA and PchAt   
 Constructs pETDuet-1-pchA/pchB, pET28b-pchA, and pET28b-pchAt add a six-
histidine tag to the N-terminal PchA and PchAt (a truncated PchA). The truncated 
PchA was generated by removal of flexible regions on both N- and C-termini 
according to the sequence alignment of PchA with Irp9 (Figure 3-6). E. coli cells with 
plasmid pETDuet-1-pchA/pchB were grown in LB broth containing 50 %g/ml with 
shaking at 225 rpm until the OD600 reached ~ 0.8. Protein expression was induced 
with an addition of IPTG to a final concentration of 0.2 mM for 3 hours. The cells 
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PchA MSRLAPLSQCLHALRGTFERAIGQAQALDRPVLVAASFEIDPLDPLQVFGAWDDRQTPCL
Irp9  -----------MKISEFLHLALPEEQWLPTISGVLRQFAEEECYVYERQPCWYLGKG---
PchA YWEQPELAFFAWGCALELQGHGEQRFAR--IEENWQLLCADAVVEGPLAPRLCGGFRFDP
Irp9  CQARLHINADGT-QATFIDDAGEQKWAVDSIADCARRFMAHPQVKGRRVYGQVG-FNFAA
PchA RGPREEHWQAFADASLMLAGITVLREGERYRVLCQHLAKPGEDALALAAYHCSALLRLRQ
Irp9  HARG----IAFNAGEWPLLTLTVPRE-----ELIFEKGN-----VTVYADSADGCRRLCE
PchA PARRRPSGPTAGAQGDASAQERRQWEAKVSDAVSSVRQGRFGKVVLARTQARPLGDIEPW
Irp9  WVKEASTTTQNAPLAVDTALNGEAYKQQVARAVAEIRRGEYVKVIVSRAIPLPS-RIDMP
PchA QVIEHLRLQHADAQLFACRRGNACFLGASPERLVRIRAGEALTHALAGTIARGGDAQEDA
Irp9  ATLLYGRQANTPVRSFMFRQEGREALGFSPELVMSVTGNKVVTEPLAGTRDRMGNPEHNK
PchA RLGQALLDSAKDRHEHQLVVEAIRTALEP--FSEVLEIPDAPGLKRLARVQHLNTPIRAR
Irp9  AKEAELLHDSKEVLEHILSVKEAIAELEAVCLPGSVVVEDLMSVRQRGSVQHLGSGVSGQ
PchA LADAGGILRLLQALHPTPAVGGYPRSAALDYIRQHEGMDRGWYAAPLGWLDGEGNGDFLVA
Irp9  LAENKDAWDAFTVLFPSITASGIPKNAALNAIMQIEKTPRELYSGAILLLD-DTRFDAALV
PchA LRSALLTPGRGYLFAGCGLVGDSEPAHEYRETCLKLSAMREALSAIGGLDEVPLQRGVA
Irp9  LRSVFQDSQRCWIQAGAGIIAQSTPERELTETREKLASIAPYLMV--------------
Figure 3-6: Sequence alignment of PchA and Irp9. Identical residues are in red, and 
similar residues are in green. PchA and Irp9 share 28% of sequence identity, and 47 
% similarity. Secondary structure elements of Irp9 structure are shown: grey box, !-
helix; white arrow, "-strand. Disorder loop in Irp9 is displayed as dotted lines. 
Loops are black lines. The amino acids highlighted in boxes are removed to generate 
a truncated PchA, referred as PchAt. 
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were pelleted by centrifugation (4,000 × g, 10 min, 4 °C) and resuspended in buffer, 
25 mM Tris-HCl, pH 8.0, 500 mM NaCl. The purification steps were performed as 
described for C-terminal His6-tag PchA.  
 Protein was overexpressed and purified from E. coli cells harboring plasmid 
pET28b-pchA or pET28b-pchAt conducted in a similar manner to C-terminal His6-
PchA with modifications. Six ml of overnight LB culture was inoculated in a 600 ml 
of TB medium containing 0.4% (v/v) glycerol and 50 %g/ml kanamycin in a 2L flask. 
Incubation was at 25 °C with shaking at 225 rpm until an OD600 of 0.4 was reached. 
Then temperature lowered to 20 °C with shaking at 225 rpm for another 12 ~ 14 h. 
The pellet were collected by centrifugation at 4,000 × g for 10 min at 4 °C and 
resuspended in buffer A1 (25 mM TrisHCl, pH 8, 500 mM KCl, 5 mM imidazole, 
20% glycerol). The cells were disrupted with sonication. The first centrifugation was 
carried out at 15, 000 × g for 30 min. The supernatant was removed and saved for the 
later use. The pellet was resuspended with buffer A1 of same amount of supernatant 
and subjected to sonication again. This second debris was combined with the 
supernatant from first centrifugation and spun at 142, 000 × g for 1 h at 4 °C. The 
resulting supernatant was applied to a sepharose column charged with NiCl2 and 
equilibrated in buffer A1. A step gradient of 15 mM, 45 mM, 150 mM and 300 mM 
imidazole in buffer A1 was applied to the column and the protein of interest eluted 
with 150 mM imidazole. Fractions were pooled and concentrated using an Amicon 
stirred cell with YM-30 membrane. Five ml of sample was applied to a HiLoad 16/60 
Superdex 200 gel filtration column equilibrated with 50 mM TrisHCl, pH 8, 50 mM 
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KCl, 50 m Na Citrate, 10% glycerol. N-terminal His6-PchA and His6-PchAt were 
eluted as a monomer (~52kDa) from gel filtration column. The fractions containing 
protein of interest were pooled and concentrated by an Amicon stirred cell YM-30 or 
a Centriprep YM-30. The concentration of protein was determined by Bradford assay, 
and the purity was ~98%. The protein samples were kept at – 80 °C. 
 
Un-His6-tagged PchA  
 To obtain un-tagged PchA,  E. coli BL21 (DE3) containing plasmid pETDuet-1-
pchB/pchA was grown and collected as described for the construct pETDuet-1-
pchA/pchB. Since pchA was inserted in MCS2 (multiple cloning site 2) of plasmid 
pETDuet-1-pchB/pchA, no His6-tag was introduced to PchA. Purification was 
achieved by an anion exchange chromatography. The cell pellet was resuspended 
with buffer 20 mM TrisHCl, pH 8.5 and lysed by passing through French Press three 
times. The pellet was removed by centrifuging at 15, 000 × g at 4 °C for 30 min. The 
supernatant was applied to a Source 30Q anion exchange column equilibrated with 20 
mM TrisHCl, pH 8. A linear gradient of 0 – 500 mM NaCl in 20 mM TrisHCl, pH 8 
was applied to the column. The fractions were analyzed on SDS-PAGE for PchA. 
 The PchA protein without His-tag was also obtained by thrombin cleavage. The 
purified N-terminal His6-PchA (expressed from pET28b-pchA) was incubated with 
thrombin in a ration of 2 units per mg PchA at room temperature for 2 h. The mixture 
was applied to nickel-charged column and eluted in the same manner as His6-PchA 
purification on nickel column. The protein without His-tag flowed through the 
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column. Fractions containing PchA were pooled, concentrated, and further purified 
on gel filtration column in buffer 50 mM Hepes, pH 7.5, 150 mM NaCl, 10% glycerol. 
  
PchA mutants 
 PchA mutants K221A, E269A, D310E and A375T were overexpressed, and 
purified in a two-step chromatography process, nickel affinity followed by gel 
filtration column as described for N-terminal His6-PchA (pET28b-pchA). 
 
Irp9 Overexpression and Purification   
 An overnight culture of BL21 (DE3) E. coli cells containing the Irp9 expression 
plasmid pET29b-irp9 were inoculated to 1 liter LB medium with 50 %g/ml kanamycin. 
The cells were grown at 37 ºC with shaking at 225 × rpm to an OD600 of ~1.3. The 
temperature was then lowered to 18 ºC for 24 hr without IPTG induction. The cells 
were harvested by centrifugation. The pelleted cells were resuspended in 25 mM 
TrisHCl pH 8.0, 500 mM NaCl, 5 mM Imidazole (buffer A) and lysed by French 
Press (35, 000 psi). The cellular debris was removed by centrifugation (15,000 × g, 
30 min, 4 °C) and supernatant was applied to a chelating Sepharose fast flow column 
charged with nickel chloride and pre-equilibrated in buffer A for nickel affinity 
chromatography. A step gradient of imidazole in buffer A was applied to the column 
and Irp9 protein eluted at 150 mM imidazole. The fractions containing Irp9 were 
pooled an applied to Superdex 200 size exclusion column equilibrated with 20 mM 
TrisHCl pH8.0, and 100 mM NaCl. After identification on SDS-PAGD, fractions 
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containing Irp9 were combined and concentrated with Centriprep (Millipore) YM-30. 
 
Protein Determination 
 The protein concentration for all samples are determined by the method of 
Bradford with the Bio-Rad Protein Assay Dye Reagent. IgG was used as a standard. 
 
Limited Proteolysis of PchA
 
 To determine areas of PchA susceptible to proteolysis, PchA was treated with a 
variety of proteases, including trypsin, subtilisin, chymotrypsin, proteinase K, papain, 
and thrombin. PchA was incubated with each protease at 4 oC and room temperature 
(22 oC). The mixture (100 %l) contained 50 µg PchA and 0.5 µg protease in the 
cleavage buffer: 20mM TrisHCl, pH 7.8, 50 mM NaCl, 1 mM DTT, 5 mM CaCl2 for 
trypsin, chymotrypsin, and subtilisin; 20mM TrisHCl, pH 7.8, 50 mM NaCl, 1 mM 
DTT for papain and proteinase K; 20 mM TrisHCl, pH 8.0, 100 mM NaCl for 
thrombin. Samples were collected at 5, 15, 30, 60, 120, and 240 min. Each sample 
was subjected to SDS-PAGE for analysis of the extent of cleavage. 
 
3.2.2 Steady-State Kinetic Studies 
Mg2+ Dependence of PchA activity 
 MST family are Mg2+-dependent enzymes. The ICS activity of PchA was 
measured under a variety of divalent cation conditions using a coupled assay. The 
assay is required 20-fold excess of PchB to convert isochorismate made by PchA to 
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salicylate, which can be measured fluorescently.7 The standard reaction mixture (200 
%l) contained 50 mM TrisHCl, pH 7.5, 10% glycerol, 1 mM DTT, 10 %M PchA, 200 
%M PchB, and 1 mM chorismate. To determine which divalent cations can support 
PchA activity, the standard reaction mixture without chorismate was preincubated 
with 1 mM EDTA for 10 min at room temperature followed by addition of 1 mM 
chorismate to initiate the reaction. Salicylate accumulation was monitored with an 
excitation wavelength of 300 nm and emission wavelength of 430 nm for 5 min. Ten 
mM MgCl2, CaCl2, NiCl2, or CoCl2 was added to each reaction with 1 mM EDTA, 
and salicylate formation was measured. Data were plotted with KaleidaGraph.  
 
Steady-State Kinetics of PchA and Mutants 
Coupled Isochorismate Synthase Measurement 
 The assay used to measure the steady-state kinetics of PchA and its mutant is 
coupled with 20-fold excess of PchB to convert isochorismate to salicylate and 
evaluate PchA ICS activity.7 The reaction buffer for ICS contained 50 mM TrisHCl, 
pH 7.5, 10 mM MgCl2, 1 mM DTT, and 10 % glycerol. The steady-state kinetic 
assays on wild type PchA were performed with 0.5 %M PchA and 10 %M PchB in the 
reaction buffer (100 %l) with chorismate concentration varying from 0.5 to 500 %M. 
The steady-state kinetic assays on mutants were performed with 1 %M PchA mutant 
enzyme and 20 %M PchB in the reaction buffer (100 %l) with chorismate 
concentration varying from 2 to 200 %M. Salicylate, a product of the coupled assay 
was measured by its fluorescence with an excitation of 300 nm and an emission of 
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430 nm. The amount of salicylate formed was determined from a salicylate standard 
curve with varied concentration of 0 – 80 %M salicylate in the reaction buffer. Kinetic 
constants Vmax, Km and kcat were calculated from Michaelis-Menten equation using 
KaleidaGraph. 
 
Chorismate Mutase Measurement 
  The CM activity on PchA mutant D310E was performed by the method 
described10 at room temperature. The reaction mixture (400 %l) contained 50 mM 
TrisHCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 10% glycerol, 50 %M D310E and 
chorismate with concentration varied between 0.1 and 5 mM. The reactions were 
initiated by the addition of chorismate. Every 15 seconds, 40 %l of reaction mixture 
was taken out and mixed with 20 %l 1M HCl to terminate the reaction. The reaction 
product prephenate was then converted to phenylpyruvate by incubation at 37 °C for 
20 min. Phenylpyruvate concentration was determined at 320 nm under basic 
condition by the addition of 140 %l of 2.5 M NaOH ($320 = 17,500 M-1 cm-1)10 on a 
UV spectrophotometer. Steady-state kinetic parameters were derived from the initial 
velocities of prephenate accumulation with KaleidaGraph. 
 
3.2.3 pH dependence of PchA catalysis 
 To determine the pH dependence of PchA catalysis, the kcat and Km of PchA ICS 
reaction was measured over a range of pH values. A multi-component buffer was 
used to cover the pH range of 6.0 through 9.5 and minimize buffer and ionic strength 
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effects. This buffer contains 50 mM MES, 25 mM Tris, 25 mM ethanolamine, 100 
mM NaCl, named 1 × MTEN.14 The kinetic assays were conducted in 1 × MTEN 
with varied pHs, 10 mM MgCl2, 1 mM DTT, 10% glycerol, 0.5 %M PchA, 10 %M 
PchB. The following measurements and data analysis were performed in a identical 
manner as described in the Coupled Isochorismate Synthase Measurement section. 
Plots of log kcat were generated with KaleidaGraph. 
 
3.2.4  Protein Crystallization 
Buffer Optimization 
Dynamic Light Scattering (DLS) 
 Before DLS measurements, centrifugation of 30 min at 15, 000 × g in a table-
top microcentrifuge was carried out to obtain a sample that is free of any dust or other 
particles. Protein samples used were at a concentration of ~ 1mg/ml in various buffer. 
The DLS data were recorded in a quartz cuvette with a light path of 5 mm using a 
PD2000 DLS (Precision Detectors). Five readings were recorded for each sample. 
Each reading was the average of 60 accumulated data points. 
 
Solubility Screen 
 Protein solubility screens were carried out as described by Isaac et al.15 with 
some modifications. 150 %l protein sample (~ 5 mg/ml) was incubated with 190 %l 
40% PEG 8,000 at room temperature for 20 min, which precipitated protein from 
solution. The protein suspension was aliquoted to 18 %l followed by addition of  2 %l 
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buffer, salt or additive to a final concentration of 100 mM salt, 10% glycerol, or 1 
mM EDTA. The mixture was incubated at room temperature for 20 min to allow for 
resolubilization of the protein. After centrifugation at 14, 000 rpm for 30 min, the 10 
%l of supernatant was mixed with 1ml of 1 × Bio-Rad Protein Assay Dye and the 
absorbance at 595 nm was measured. 
 
Protein Crystallization 
Standard Crystallization  
 Protein crystallization was performed using hanging-drop, sitting-drop and 
sandwich-drop vapor diffusion methods and incubated at room temperature, 18 ºC or 
occasionally 4 ºC. The drop size is normally 3 %l with a protein to reservoir solution   
ratio of 1 to 1, 1 to 2, or 2 to 1 (v/v). The protein samples subjected to crystallization 
trials were either apo-, mixed with substrate or PchB. 
 
Optimization 
 After initial screens, the crystallization hits would be subjected to cycles of 
optimization to improve the quality of initial crystals. Several standard optimization 
approaches were performed in this chapter.16  
 The first attempt was to refine around the initial successful condition with an 
increment matrix, such as pH versus salt, salt versus precipitant etc. Then temperature 
of crystallization would be optimized at 4, 11, 18, and 25 °C. A various additives can 
also introduce into crystallization condition. Table 3-3 listed the additives used in this 
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Additive Class
0.1M Cadmium chloride hydrate Multivalent
0.1M Calcium chloride dihydrate Multivalent
0.1M Cobalt(II) chloride hexahydrate Multivalent
0.1M Magnesium chloride hexahydrate Multivalent
0.1M Iron(III) chloride hexahydrate Multivalent
0.1M Nickel(II) chloride hexahydrate Multivalent
1.0M Ammonium sulfate Salt
1.0M Potassium chloride Salt
1.0M Lithium chloride Salt
2.0M Sodium chloride Salt
0.5M Sodium fluoride Salt
1.0M Sodium iodide Salt
0.1M Strontium thiocyanate Salt
1.0M Sodium potassium tartrate dihydrate Salt
1.0M Sodium citrate tribasic dihydrate Salt
1.0M Cesium chloride Salt
1.0M Sodium malonate pH 7.0 Salt
0.1M L-Proline Amino Acid
30% v/v Dimethyl sulfoxide Dissociating Agent
1.0M Glycine Linker
0.3M Gly-Gly Linker
0.1 M Taurine Linker
0.1 M Betaine Linker
1.0 Guanidine hydrochloride Chaotrope
0.1 M Urea Chaotrope
0.1 M TCEP hydrochloride Chaotrope
0.1 M EDTA disodium salt dihydrate Chelating Agent
5% w/v Polyvinylpyrrolidone K15 Polymer
10% w/v Polyethylene glycol 3,350 Polymer
30% w/v D-(+)-Glucose Carbohydrate
30% w/v Sucrose Carbohydrate
30% w/v D-(+)-Galactose Carbohydrate
30% Ethylene glycol Polyol
50% w/v PEG 400 Organic, Non-volatile
50% v/v Jeffamine M-600 pH 7.0 Organic, Non-volatile
40% v/v 1,6-Hexanediol Organic, Non-volatile
30% v/v Ethanol Organic, Non-volatile
30% v/v Methanol Organic, Non-volatile
40% v/v 1,4-Butanediol Organic, Non-volatile
40% v/v Acetonitrile Organic, Non-volatile
1.0 M Sodium tartrate Salt
40% v/v 1-Propanol Organic, Non-volatile
30% Glycerol
7% v/v 1-Butanol Organic, Non-volatile
5% Ethyl acetate Organic, Non-volatile
40% Acetone Organic, Non-volatile
 
Table 3-3: Additives for crystallization optimization. 
(Adapted from Hampton Research) 
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chapter. Alternate diffusion methods were conducted, including sitting-drop, 
sandwich-drop vapor diffusion methods. Seeding experiments including microseeding 
and macroseeding were also performed as described using ball-shaped PchA crystals 
(in sodium formate, pH 7.0) as seeds.17  
 
3.3 Results and Discussion 
Protein Production 
 Various constructs of PchA, such as N-terminal His6, C-terminal H6 PchA, 
PchA without tags, truncated PchAt were generated to improve yields of protein 
expression and produce suitable sample for crystallization experiments. Each protein 
was subjected to gel filtration as the last step of purification, which suggested that 
PchA is a monomer (52 kDa) in solution. Irp9 eluted as a dimer from gel filtration 
column which is consistent with published data.8 PchA mutants K221A, E269A, 
D310E, and A375T have a superimposable elution profile of gel filtration to wild type 
(Figure 3-7), which suggested that single active site mutation acts as monomer in 
solution without causing oligomerization. The yield of PchA was improved from ~ 10 
to 100 mg per liter of culture after a series of optimizations of E. coli growth 
conditions, protein expression conditions (such as temperature, IPTG concentration, 
and post-induction time), and buffers for chromatography. The best conditions 
determined so far can be applied to the constructs that use pET28b as a vector for 
PchA, which are summarized in Table 3-4. The purity of each PchA variant was 
determined to ~98% by SDS-PAGE. 
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Figure 3-7: Superposition of wild type and mutants PchA elution 
profiles from Superdex 200 gel filtration chromatography. The 
elution volume at ~ 80 ml corresponds to a protein with a 
molecular weight of 52 kDa as PchA. 
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Protein over-production 
Medium Terrific broth with 0.4 % glycerol 
Pre-induction temperature 25 °C 
OD600 at induction 0.3 ~ 0.4 
IPTG concentration 0 mM 
Post-induction temperature 20 °C 
Incubation time after induction 12 ~ 14 hours 
Protein preparation for chromatography 
- Resuspend cell pellet in Buffer A1 
- Lyse cells by sonication 
- Spin 1st lysate by regular spin (14, 000 rpm, 30 min, 4 °C) 
- Save supernatant and resuspend pellet in buffer A1 
- Lyse sample by sonication 
- Combine 2nd lysate with 1st supernatant 
- Ultracentrifuge with 35,000 rpm, 1 h, 4 °C 
Protein purification 
Buffer A1 (for resuspending cells and 
Nickel column) 
25 mM TrisHCl,  pH8.0, 500 mM KCl, 5 
mM imidazole, 20% glycerol 
Buffer B (Nickel column) 25 mM TrisHCl,  pH8.0, 500 mM KCl, 
300 mM imidazole, 20% glycerol 
Nickel Step Elution - 10 % buffer B, 5 CV 
- 15 % buffer B, 5 CV 
- 50 % buffer B, 6 CV 
Buffer for gel filtration 50 mM TrisHCl,  pH8.0, 50 mM KCl, 50 
mM Na Citrate, 10% glycerol 
CV: column volume  
Table 3-4: Optimized conditions for PchA over-production and purification  
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 Limited proteolytic analysis was conducted on PchA to identify flexible region 
on the protein, which might be a reason that interferes protein crystallization. If a 
small region on PchA could be removed after proteolysis, then the protein would be 
re-cloned to remove the regions and crystallization trials would be performed. Six 
proteases were tested and the aliquots from different time points were analyzed on 
SDS-PAGE. The goal was to determine if small region can be cleaved off from PchA 
without complete degradation. All proteases tested, including trypsin, subtilisin, 
chymotrypsin, proteinase K, papain, and thrombin, resulted in large degradation 
products with complete formation of small fragments on SDS-PAGE (data not 
shown), which was unsuitable for continued experiments.  
 
Mg2+-Dependence of PchA Catalysis 
 PchA homologs MenF and Irp9 require Mg2+ to align substrate and allow for 
catalysis to happen. Mg2+ is also evident in the structures of MenF and Irp9. To 
determine if Mg2+ is also required for PchA activity, 1 mM EDTA was pre-incubated 
with PchA reaction mixture. PchB is not a metal dependent enzyme; therefore the 
divalent cation condition would not affect the conversion of isochorismate to 
salicylate by PchB in the coupled reaction. The salicylate fluorescence was recorded 
over 5 min (Figure 3-8). The EDTA pre-treated sample did not have detectable 
salicylate formation over 5 min, indicating that PchA was not capable of making 
isochorismate from chorismate in the absence of Mg2+. Various divalent cations were 
added to the EDTA pre-treated reaction mixture to determine which one could restore  
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Figure 3-8: Mg2+- dependence of PchA catalysis. 
  
104 
salicylate formation. Four divalent cations were examined: MgCl2, CaCl2, NiCl2, and 
CoCl2 with a final concentration of 10 mM in the reaction solution. MgCl2 fully 
restores the catalytic function of PchA with an increase of ~ 200 a.u fluorescent 
intensity in 5 min. CaCl2 restores a trace of catalysis, likely because its size and 
chemical properties are similar to Mg2+. The data support that PchA requires Mg2+ to 
gain fully function. 
 
Steady-State Kinetics 
 PchA isochorismate activity was measured using a coupled assay with PchB.7 
Since conversion of chorismate to isochorismate is the limiting step during this two-
step process to produce salicylate, addition of 20-fold excess of PchB ensures all 
isochorismate is immediately converted to salicylate. Therefore, the kinetic 
measurement could represent the catalysis from PchA. In the reaction, 10 mM MgCl2 
was added to achieve fully active PchA.7 The fluorescence of accumulated salicylate 
was recorded over 2 min with excitation wavelength of 300 nm and emission 
wavelength of 430 nm. To gain insight into the mechanism of PchA, four active site 
single mutations were constructed and purified for kinetic studies: K221A, E269A, 
A375T, and D310E.  
 Isochorismate differs from chorismate by the location of the hydroxyl group. It 
was proposed by Liu et al.18 that the hydroxyl group of isochorismate came from 
water. A nucleophile from enzyme would facilitate the attack of water on C2 of 
chorismate. Later on, structures of MenF (K190) and Irp9 (K193) supported this idea 
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by trapping a water molecule in their active sites with a Lys nearby (Figure 3-2b, and 
3-4b). However, mutation of K190A in MenF had no activity.2 Lysine is a conserved 
residue in MST family and hence considered as a general base that helps with 
nucleophilic addition of water to C2-chorismate. We hypothesized that the 
corresponding K221 is the general base for PchA catalysis. The replacement of Lys 
by Ala in PchA results in an inactive enzyme (Table 3-5), which is consistent with 
result from homolog MenF. PchA catalysis is dependent on K221 that may be serve 
as the general base. 
 Glu is another conserved amino acid found in proximity to ligands in the active 
sites of MenF (E240) and Irp9 (E240). The mutations of E240A in Irp9 and E240Q in 
MenF led to complete loss of catalytic efficiencies.2,4 This residue is in a position to 
interact with the C4-OH of chorismate, promoting departure of the hydroxyl group 
from C4 by serving as a general acid.4 In PchA, the corresponding amino acid is 
Glu269. Mutation of  E269 in PchA to Ala results in an inactive enzyme (Table 3-5), 
which suggests that Glu is required for catalysis at this position probably acting as the 
general acid. Further experiment of pH dependence of PchA catalysis was carried out 
to confirmed this reaction mechanism, which will be discussed later on. 
 As shown in Figure 3-5, Ala375 in PchA is conserved in ICS enzymes, whereas 
a Thr resides at this position in salicylate synthases. The backbone carbonyl group of 
Thr348 in Irp9 H-bonds to hydroxyl group of salicylate. It was suggested that this H-
bond may be important to orient the isochorismate intermediate in salicylate synthase, 
leading to an IPL activity. One can suppose that change of Ala into Thr in ICS might  
 106 
 
 
 
 
 
 
  
 
Km (!M) kcat (min-1) kcat / Km 
 
(M-1s-1) 
% WT  
(kcat / Km) 
Wild type 1.3 ± 0.03 3.3 ± 0.1 42000 100 
K221A n.a. n.a. - - 
E269A n.a. n.a. - - 
A375T 120 ± 3 0.48 ± 0.01 69 0.16 
D310E 2.2 ± 0.2 2.4± 0.1
 
18000 43 
 
 
Table 3-5: PchA isochorismate synthase activity   
n.a. = no activity; n = 3 
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give rise to IPL activity in these enzymes. However, mutation of Ala344 into Thr in 
MenF did not result in gain of IPL activity but instead produced inactive enzyme.2 
The corresponding residue in PchA was mutated to Thr (A375T). The mutation 
decreases the ICS activity (kcat/Km) by ~ 600-fold with ~ 90-fold increase in Km and ~ 
7-fold decrease in kcat (Table 3-5). The large decrease in catalytic efficiency was 
mainly due to increase in Km, likely resulting from an slight alteration in active site 
architecture that lowers the substrate affinity and orientation. 
 
Mutant D310E 
 Asp (D310 in PchA) is the second nonconserved amino acid (Figure 3-5), which 
is changed to Glu in salicylate synthase. The role of Glu is to coordinate Mg2+ 
through water. The shorter Asp in PchA may cause a shift of Mg2+ toward D310 in 
the active site and thus slightly shift the site of catalysis relative to the active site in 
salicylate synthase. We hypothesized that this change in active site could be the cause 
of loss of IPL activity in PchA. By replacing this Asp at the position 310 with Glu, 
the IPL activity may be created. 
 PchA D310E shows a reduction in ICS catalytic efficiency by ~ 60% (Table 3-
5). To determine if this mutation has IPL activity, a reaction was performed in a 
similar manner as the coupled ICS assay in the absence of PchB. Salicylate formation 
was detected, indicating the recurrence of IPL activity in D310E. Chorismate mutase 
activity was also observed by measuring prephenate formation. The kinetic 
parameters for ICS and CM reactions catalyzed by D310E are summarized in Table 
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3-6. The catalytic efficiency for ICS is dominant over CM activity by ~ 3 × 103-fold 
in D310. Therefore, chorismate can bind to D310E in two orientations with formation 
of isochorismate (ICS) preferred over prephenate (CM). The Km for ICS activity (2.2 
%M) is much smaller than the Km for CM activity (1521 %M) and the ICS reaction rate 
is ~5-fold fasted than the CM rate. The IPL activity of D310E is proposed to perform 
the pericyclic reaction in the same way as PchB does. 
 
pH Profile of PchA  
 In order to examine the required protonation state of the reactive group and the 
acid base mechanism, the preliminary pH rate profiles of the kinetic parameter kcat 
was determined over the pH range of 6 to 9.5 as shown in Figure 3-9. The reaction 
rate catalyzed by PchA decreases at both low and high pH with the highest rate at pH 
~ 7.5. The bell-shaped pH curve indicates that two possible ionization groups relate to 
the reaction rate, one group getting protonated and the other getting deprotonated for 
maximal activity. One candidate is K221 as the general base activating water that acts 
as nucleophile attacking C2-chorismate. The other is E269 as the general acid to 
facilitate the removal of C4-OH on chorismate. pKa for the two ionizable groups 
involved in catalysis can be obtained from inflection points in the graph of log kcat 
versus pH and log (kcat/Km) versus pH using the equation described by Cook and 
Cleland.19 In order to demonstrate the general acid and base reaction mechanism, the 
solvent deuterium isotope effects on isochorismate formation catalyzed by PchA wild 
type and mutants can be measured, which will indicate if the proton-transfer is 
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Activity Km (!M) kcat (min-1) kcat / Km 
 
(M-1s-1) 
WT PchA ICS 1.3 ± 0.03 3.3 ± 0.1 42000 
D310E ICS 2.2 ± 0.2 2.4± 0.1
 
18000 
D310E CM 1521 ± 469 0.48 ± 0.03 5.3 
Table 3-6: D310E kinetics parameters 
n=3 
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Figure 3-9: The pH dependence of the PchA reaction rate. 
PchA exhibits the highest reaction rate when the pH is 7.5. This 
preliminary pH curve is bell-shaped, indicating two ionization 
processes taken place during PchA catalysis. This data suggests 
the general acid and base catalysis conducted by PchA to 
convert chorismate to isochorismate. 
lo
g 
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rate-limiting. The results from mutagenesis, and preliminary pH-dependence of PchA 
kinetic parameters suggest that both K221 and E269 are critical for catalysis, most 
likely as the general base and acid.  
 
PchA Crystallization 
Buffer Optimization Screen 
 To improve PchA protein solubility for purification and crystallization, a buffer 
optimization screen was performed as described.15 Protein precipitated by 40% PEG 
8000 was resolubilized by the addition of 100 mM buffer, 100 mM salts, 10% 
glycerol, 1 mM DTT, 1 mM EDTA, respectively. Water was used as a blank. 
Additives promoting higher protein solubility would correspond to a larger 
absorbance reading at 595 nm. Results are summarized in Figure 3-10 for PchA and 
Figure 3-11 for PchAt. According to those results, buffer components were selected 
for different purification steps to achieve best outcome. Buffers for PchA purification 
are described in Table 3-4.  
 
Crystallization Trials 
 To gain insight into the PchA mechanism for catalysis, we attempt to solve the 
atomic atomic structure of PchA by crystallography. Therefore, crystallization of 
PchA and mutants were carried out in this section. The crystallization screens that 
have been performed for PchA and truncated PchAt are summarized in Table 3-7. 
Among all the trial done, only one gave a positive result, which was crystallized in 
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Figure 3-10: PchA buffer optimization screen.  
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Figure 3-11: PchAt buffer optimization screen.  
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Screens 
Protein Protein buffer Additive/ 
other 
Te
m
p 
(°C
) 
In
de
x
™
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ltR
x
™
 
Cr
ys
ta
l S
cr
ee
n
™
 
Cr
ys
ta
l S
cr
ee
n
 
2™
 
PE
G
/Io
n
 
Sc
re
en
™
 
W
iz
ar
d 
I 
W
iz
ar
d 
II
 
PchA 
18 mg/ml 
50mM Tris, pH8, 100 
mM Nacl, 1 mM 
DTT, 10% Glycerol 
None 25 × × × × ×   
PchA 
7 mg/ml 
50 mM Hepes pH 7.5, 
10 mM MgCl2, 1 mM 
DTT, 10 % Glycerol 
None 25 × × × × ×   
PchA  
12 mg/ml 50 mM Tris pH 7.5 Chorismate 25 × × × × × × × 
PchA 
11 mg/ml 
50mM Hepes pH 7.5,, 
150 mM Nacl, 1 mM 
DTT, 10% Glycerol 
PchB 25 × × × × × ×  
PchA (no 
His-tag) 
17 mg/ml 
50 mM Hepes pH 7.5, 
150 mM NaCl, 10% 
Glycerol 
None 25 × × × × ×   
PchA 
(no His-
tag) 
10 mg/ml 
50 mM Bis-Tris 
Propane, pH7.0, 150 
mM NaCl 
None 25 × ×  × ×   
PchA (no 
His-tag) 
15 mg/ml 
50 mM Tris pH 8.0, 
150 mM NaCl None 25 × × × × × × × 
PchA 
14 mg/ml 
50 mM Hepes pH 7.5, 
0.5 mM Na Formate, 
1 mM DTT, 10% 
Glycerol 
None 18 × × × × ×   
Table 3-7: Summary of PchA and PchAt initial matrix crystallization screens 
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Screens 
Protein Protein buffer Additive/ 
other 
Te
m
p 
(°C
) 
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2™
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™
 
W
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d 
I 
W
iz
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d 
II
 
PchAt 
14 mg/ml 
50 mM ADA pH 7.0, 
100 mM Na Citrate None 25 ×  × × ×   
PchAt 
17 mg/ml 
50 mM Tris pH8.0, 
100 mM Na Citrate, 
10 % Glycerol 
None 18 × × × × ×   
PchAt (no 
His-tag)  
12 mg/ml 
50 mM Tris pH8.0, 
100 mM Na Citrate, 
10 % Glycerol 
None 18 × × × × × × × 
PchAt 
18 mg/ml 
50 mM Tris pH8.0, 
100 mM Na Citrate, 
10 % Glycerol 
Salicylate 
& Pyruvate 18 × × × × × × × 
×: screen performed.  
Continued 
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 3.5 M sodium formate, pH 7.0 from the initial matrix Index™ (Hampton Research) 
(Figure 3-12). A series of optimization cycle were conducted to change the 
morphology of this crystal, which all failed to change this ball-shaped crystal.  
 
Irp9 Crystallization and Data Collection 
 Irp9, a PchA homolog, is the salicylate synthase in Y. enterocolitica. The goal 
was to solve the structure of Irp9 that would serve as a research model for PchA. The 
Irp9 clone was constructed, and the protein over-produced and purified. The activity 
assay suggested that Irp9 was capable of making salicylate from chorismate (data not 
shown). Initial matrix screens were conducted on Irp9, in which four conditions 
successfully gave rise to crystals. After optimization by fine increments, diffraction 
quality Irp9 crystals were obtained (crystallized in 0.1M TrisHCl, pH 8.0, 0.16 M 
CaCl2, 13% PEG 3350) (Figure 3-13 inset). Native diffraction images were collected 
in the Protein Structure Lab at the University of Kansas. A single diffraction image is 
shown in Figure 3-13. The crystal diffracts to 2.55 Å. Data collection statistics are 
summarized in Table 3-8. However, at this point in our studies Kerbarh et al.4 
published the Irp9 structure. Comparision of our data to theirs revealed many 
similarities. The Irp9 eluted from gel filtration as a homodimer in our experiment in 
agreement with their structure of homodimer per asymmetric unit. Both have the 
same space group of P21. Our unit cell was with a = 56.69 Å, b = 161.26 Å, c = 58.93 
Å, whereas with a = 56.74 Å, b = 145.67 Å, c = 58.81 Å in theirs.  
 In summary, we have demonstrated that PchA catalyzes isochorismate 
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 Figure 3-12: PchA crystallized in 
sodium formate, pH 7.0. The crystal 
was demonstrated as a protein crystal 
by blue dye and crushing techniques. 
The morphology of this ball-shaped 
crystal was not improved after a variety 
of crystallization optimization attempts. 
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Figure 3-13: A diffraction image of Irp9. The inset of this figure 
is the Irp9 crystal subjected for data collection. This crystal 
diffracts to 2.5 !. 
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 Apo Irp9 
Rsolution Range (!) 50-2.55 
Space Group P21 
Unit Cell (!) a = 56.69, b = 161.26, c = 58.93 
 " = # = 90°, $ = 109.66° 
Obsrvations  
 Unique 23, 951 
 Total 58, 296 
Completeness (%)* 87.0 (73.8) 
Rsym % 12.6 (39.9) 
% I > 3 % 67.8 (46.5) 
Table 3-8: Data collection statistics 
*Values in parentheses are for the highest resolution shell ( 2.64-2.55 !) 
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formation by a general acid and base mechanism, in which Lys 221 and Glu 269 play 
roles as the general base and general acid, respectively, during catalysis. Our work 
also established a novel salicylate synthase  from a isochorismate synthase by a single 
amino acid  substitution on PchA. The mutant enzyme D310E will further our 
understanding  of chorismate-utilizing enzymes.  
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CHAPTER 4 
 
High Throughput Screening of Inhibitors of  
Salicylate Synthesis in Pseudomonas aeruginosa 
 
4.1 Introduction 
 Salicylate serves as a precursor for biosynthesis of some siderophores, including 
pyochelin in P. aeruginosa, yersiniabactin in Yersinia spp., mycobactin in M. 
tuberculosis.  Chorismate is converted to salicylate either via a two-step process by 
PchA and PchB in P. aeruginosa, or via a single step by salicylate synthase enzymes 
in Yersinia spp. and M. tuberculosis. Derived from shikimate pathway, chorismate is 
the general precursor for a wide variety of other aromatic metabolites critical for 
bacteria and fungi growth, such as aromatic amino acids phenylalanine, tyrosine, and 
tryptophan; folate; ubiquinones; and menaquinones. These chorismate-utilizing 
pathways are attractive targets for the development of antimicrobial drugs because 
there are no similar pathways present in humans. Conversion of chorismate to various 
intermediates is the first committed step toward the generation of necessary 
compounds by five classes of chorismate-utilizing enzymes, including isochorismate 
synthase (ICS), anthranilate synthase (AS), aminodeoxychorismate synthase (ADCS), 
chorismate mutase (CM), and chorismate-pyruvate lyase (CL).  
  The ICS, AS, and ADCS enzymes catalyze conversions of chorismate to 
isochorismate, anthranilate, and aminodeoxychorismate, respectively. These three 
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chorismate-utilizing enzymes are related to each other by approximately 20% protein 
sequence homology. They share conserved active sites and display similar 
mechanisms.1 Recent studies found that salicylate synthases convert chorismate to 
salicylate via an identifiable isochorismate intermediate and display similar active 
sites as ICS.2-4 Members of CM share no sequence homology with the three 
chorismate-utilizing enzymes mentioned above. In addition enzymes of this family 
have relatively low sequence homologies among themselves. However, their active 
sites are conserved, catalyzing formation of prephenate for phenylalanine and 
tyrosine biosynthesis pathways through a conserved mechanism.5,6 Given the 
importance of metabolites generated from chorismate and similarities of chorismate-
utilizing enzymes, these enzymes are likely to be good targets for inhibition studies 
which will block the synthesis of aromatic metabolites, and hence bacterial growth 
and virulence.  
 In this chapter, the salicylate biosynthetic pathway in P. aeruginosa was 
subjected to the high throughput (HTS) experiment of searching small molecule 
inhibitors that would potentially serve as broad-spectrum antimicrobial reagents for 
Pseudomonas, Yersinia, and Mycobacterium infections, or as part of cocktail 
therapies for those infections. PchA and PchB are involved in salicylate synthesis 
from chorismate in P. aeruginosa. There are reasons why finding inhibitors for 
salicylate biosynthesis catalyzed by PchA and PchB is interesting. First, salicylate is 
required for siderophore assembly in P. aeruginosa, thus by cutting the supply of a 
crucial building block of iron chelators, P. aeruginosa would have problems with iron 
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uptake in the host environment. Second, through screening inhibition for the bi-
enzyme reaction system, candidates that are capable of inhibiting salicylate formation 
may be relevant to homologous chorismate-utilizing enzymes of other pathogenic 
bacteria.  
  
4.2 Materials and Methods 
Protein Overproduction and Purification 
 PchB overexpression and purification were carried out as described using 
plasmid pET29b-pchBs.7 For PchA purification, the plasmid pET28b-pchA was 
transformed into E. coli BL21 (DE3) competent cells. The overproduction and 
purification were as summarized in Table 3-4 (Chapter 3).  
 
Chorismate Preparation 
Bacterial Growth and Chorismate Accumulation  
 Chorismate was purified from Klebsiella pneumoniae 62-1 as described8 with 
some modifications. Five ml of K. pneumoniae 62-1 overnight culture (grown at 30 
°C with shaking at 250 rpm) was inoculated into 1 L of growth medium (Table 4-1) 
and incubated at 30 °C, shaking at 250 rpm until OD625 of ~ 2.0. The cells were 
collected by centrifugation at 6,000 × g for 10 min at 4 °C. The cell pellet was 
resuspended in 1 L accumulation medium (Table 4-1). The resuspension was then 
incubated at 30 °C with shaking of 250 rpm for 16 to 18 h. After centriguging the 
culture at 6,000 × g, 4 °C for 30 min, the supernatant was adjusted to pH 8.5 by 
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Overnight Medium  
Nutrient Broth 0.4 g / 50 ml 
Growth Medium (1 liter)  
Yeast extract 2 g 
Casein hydrolysate 2 g 
Citric acid 2 g 
MgSO4!7H2O 0.41 g 
Na2HPO4 13.5 g 
KH2PO4 1 g 
NH4Cl 2 g 
Tryptophan 41 mg 
Accumulation Medium* (1 liter) 
Glucose 10 g 
Na2HPO4 19.2 g 
KH2PO4 2.05 g 
NH4Cl 2.7 g 
200 mM MgCl2 425 "l 
10 mM Tryptophan 1.5 ml 
 
 
 
Table 4-1: Media for K. pneumonia 62-1 growth and 
chorismate secretion 
*No need to sterilize and prepare freshly 
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slowly adding 20 M NaOH on ice, which prevented the sample from heating.  
 
Anion-exchange Chromatography of Accumulation Supernatant 
 Prior to purification, approximately 150 ml of Dower-Cl 1×8 resins (Sigma) 
was washed with 1 M of HCl, H2O, 1 M NaOH, and then completely rinsed with H2O. 
Unless othwise specified, the following steps were carried out at 4 °C due to the 
labile chorismate. The resin was mixed with the supernatant of 5 L accumulation 
culture and stirred for 30 min. The resin with chorismate bound was washed with 300 
ml of H2O three times before packed into an XK 50/20 column (GE Healthcare). The 
column was connected to an FPLC system and eluted with 3 CV (column volume) of 
2 M NH4Cl, pH 8.5 at 5 ml/min after equilibrium with 1 CV of H2O. Each fraction of 
10 ml was collected. Ten µl of each fraction was taken out and diluted by adding to 1 
ml of H2O followed by measurement of the OD275. Fractions with the OD275 over 0.3 
were pooled and acidified to pH 1.5 using 10 M HCl. 
 
Organic Extraction and Crystallization of Chorismate 
 Chorismate was extracted three time from the acidified solution with equal 
volume of ice-cold ether. The ether extracts were pooled and dried with anhydrous 
MgSO4 for 20 min on ice. After filtered to remove MgSO4 solids, the ether extract 
was concentrated to less than 50 ml using rotary-evaporation at 22 °C. Light 
petroleum ether was slowly added to concentrated ether until the solution remained 
cloudy for a few seconds before clearing. The mixture was then cooled on ice to 
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allow chorismate to crystallize from the ether. Scratching against the glass wall was 
used to promote nucleation of chorismate crystals. After chorismate crystals were 
developed for 2 h, more light petroleum ether was added to promote the complete 
crystallization of chorismate. The yellow chorismate crystallites were filtered and 
vacuum-dried over P2O5 at 4 °C overnight. 
 Recrystallization of chorismate was conducted to remove yellow contaminants. 
The chorismate was dissolved in a minimal amount of ether with stirring. A small 
amount of activated charcoal was added to remove yellow impurities followed by 
removal of charcoal by regular filtration. The chorismate was the recrystallized from 
ether by the addition of an equal amount of methylene chloride and two volumes of 
hexane. The chorismate crystals were allow to develo at 4 °C for 2 h, followed by the 
addition of more hexane to ensure full recrystallization of chorismate. Chorismate 
crystals were filtered and dried over P2O5 under vacuum at 4 °C for overnight, then 
stored at – 80 °C. 
 
Coupled Assay for HTS 
 In order to transform the assay from cuvette to a HTS microplate, the coupled 
assay9 of PchA and PchB was modified from that previously described. The enzymes 
concentration versus substrate concentration were optimized using a matrix to obtain 
the best condition with linear production formation over at least 20 min. The reaction 
solution (70 %l) that gave the best result is composed of 50 mM TrisHCl, pH 7.5, 10 
mM MgCl2, 1 mM DTT, 10% glycerol, 20 %M PchA, 20 %M PchB, and 5 mM 
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chorismate. Salicylate accumulation was measured with excitation of 300 nm and 
emission of 430 nm using a Cary Eclipse fluorescence spectrophotometer (Varian) 
with a high-speed photomultiplier tube (PMT) detector voltage of 800 V. 
 
HTS of Inhibitors of Coupled PchA and PchB Reaction 
 Purified PchA, PchB, chorismate and reaction buffers were sent to the High 
Throughput facility at The University of Kansas. The final assay development and 
validation, and the compound library screens were conducted by researchers at HTS 
facility. 
 
4.3 Results and Discussion 
 The purpose of HTS is to identify inhibitors for PchA or PchB through 
screening for inhibition of salicylate production. To initiate screen of compound 
libraries, sufficient amounts of enzymes are required. Using the protocols described 
herein 15 g of PchA and 3.5 g of PchB were produced for these purpose.  
 Substrate chorismate is commercially available, however is extremely expensive 
with a price of $979 for 100 mg of 80% purity (Sigma). To produce 16 g of 
chorismate that HTS estimated would be required to do the screening with purity 
above 90%, K. pneumoniae 62-1 was used for biosynthesis of chorismate. K. 
pneumoniae 62-1 is a triple mutant that blocks the aromatic amino acid biosynthesis 
in this strain, leading to secretion of chorismate into medium in presence of 
tryptophan.10 The average yield was ~ 400 mg/L of 60 to 70% pure chorismate (from 
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crystallization process).8 The recrystallization process resulted in ~ 90% pure 
chorismate as evaluated by the HPLC analysis and 1H-NMR spectrum (Figure 4-1), 
but decreased yields by half. The final yield of chorismate was ~ 200 mg/liter 
accumulation medium and a total of 15.6 mg 90% pure chorismate was produced. 
 A preliminary experiment was conducted to ensure that the enzymes and 
substrate were active in a 384-well plate used in the HTS experiment. Figure 4-2 
shows the fluorescence of salicylate production over time, comparable to the reaction 
described in chapter 3. The pure chorismate was also subjected to NMR experiment. 
The proton NMR spectrum of chorismate indicates the highly pure chorismate, which 
is consistent with the published data.11,12 
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Figure 4-1: 1H-NMR spectrum of chorismate purified from K. 
pneumonia 62-1. The resonances arising from chorismate H1, H5, H6, 
and HA in the region of 5.0 – 7.0 ppm. There is no presence of 
contaminants after 7.0 ppm.  
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Figure 4-2: Coupled PchA and PchB assay using 
chorismate purified from K. pneumoniae 62-1. The 
fluorescent intensity of salicylate was monitored.  
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CHAPTER 5 
 
Conclusion 
 
 During infections, pathogenic bacteria encounter an environment of iron 
starvation due to the strictly controlled iron homeostasis in mammal hosts. To cope 
with the requirement of iron for growth, colonization, and virulence, these bacteria 
have evolved several ways to extract iron from hosts. One of these is to excrete and 
reuptake siderophores, small organic compounds with extremely high affinity for 
ferric iron.1 In Pseudomonas aeruginosa two siderophores, pyochelin and pyoverdin, 
are secreted during its infection and associated with its virulence.2 Salicylate serves as 
a precursor for the phenolate-type siderophore, pyochelin. Since siderophore 
production is related to virulence, the inhibition of siderophore biosynthetic enzymes 
could lead to reduction in virulence and could provide a basis for the development of 
novel antimicrobial drugs.  
 This thesis focuses on two enzymes, PchA and PchB, which are responsible 
for salicylate biosynthesis in P. aeruginosa. The ultimate goal of this research is to 
elucidate how these enzymes promote chemical reactions in their active sites 
biochemically and structurally. Information obtained would provide a scaffold for the 
development of antimicrobial agents for P. aeruginosa infections, which could also 
extended to other pathogenic bacteria that also produce phenolate-type siderophore, 
including Yersinia sp. and Mycobacterium tuberculosis. 
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 PchB has not only a physiological role as isochorismate-pyruvate lyase, IPL to 
transform isochorismate to salicylate, but also an adventitious activity as a chorismate 
mutase, CM to rearrange chorismate to prephenate.3 Structural and mechanistic 
analyses of wild type PchB suggest that catalytic events of both IPL and CM take 
place in a single active site without formation of any covalent intermediates.4 CMs, 
PchB structural homologues, have been in the center of studies for the origin of 
enormous catalytic power of enzymes. The transition state stabilization theory 
proposes that CM active site provides an electrostatic environment that would 
accommodate the developing negative charge in the transition state, such that the 
activation energy barrier is lowered, and hence achieve the rate acceleration.5 The 
reactive substrate conformation believes that chorismate preorganized into a reactive 
conformer (defined as a near-attack conformation, NAC by Bruice and co-workers) 
that is constrained and stabilized by the enzyme active site, which will promote 
substrate progression to the transition state without any further requirement for 
energy inputs.6  
 An active site residue (Lys42) residing in the mobile loop between the first 
two helices is proposed to be critical for catalysis.4 In chapter 2, PchB active site 
(Lys42) mutants were examined to determine the relative contributions of the 
transition state stabilization and reactive substrate destabilization during CM and IPL 
catalysis. For CM activity, a positive charge at position 42 is critical for efficient 
catalysis, indicating that the transition state stabilization serves as the major source of 
CM catalysis. However, in order to maximize catalytic efficiency, a reactive substrate 
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conformation is required to adapt in the active site for CM catalysis. For IPL activity, 
stabilizing the transition state and the reactive substrate conformer are required for 
catalysis, but not to the same extent. From this chapter, we conclude that  while 
formation of a reactive substrate conformer is a prerequisite for pericyclic reactions 
catalyzed by PchB, electrostatic stabilization of the transition state would provide the 
means by which the enzyme obtain efficient catalysis.  
 PchA is an isochorismate synthase, catalyzing an isomerization of chorismate 
to isochorismate, which is the first step in salicylate biosynthesis in P. aeruginosa.7 In 
Yersinia sp. and M. tuberculosis, salicylate synthesis only requires a single enzyme, 
salicylate synthase, to generate salicylate from chorismate via an isochorismate 
intermediate.8, 9 The question addressed in chapter 3 is why PchA does not have the 
ability to perform the second reaction in salicylate synthesis pathway, even it has high 
sequence homology with salicylate synthases in Y. enterocolitica and M. tuberculosis. 
By comparing the sequence between PchA and structure-known salicylate synthase 
Irp9,10 four active site amino acids achieved attention. Two conserved amino acids 
among chorismate-utilizing enzymes, K221 and E269 in PchA, are responsible for the 
general acid and base catalytic reaction mechanism. Replacements of these two sites 
by alanine resulted in complete loss of catalytic efficiency in PchA. The pH profile 
for PchA exhibits a bell-shaped curve, which suggests that two ionizable groups 
participate in catalysis. Taken together, these results suggest that activation of a water 
molecule by K221 as a general base promotes the nucleophilic attack on C2, and 
E269 acts as a general acid to facilitate departure of hydroxyl group from C4 on 
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chorismate, as proposed for mechanism of conversion of chorismate to isochorismate 
by PchA. The other two amino acids selected to study are non-conserved between 
salicylate synthase and isochorismate synthase. Our purpose is to investigate whether 
a mutation of non-conserved amino acid to the corresponding counterpart in salicylate 
synthase would be able to transform isochorismate synthase into salicylate synthase. 
PchA D310E gave promising results in that replacement of only a single residue, 
enzyme creates two additional activities, CM and IPL. These three activities, ICS, 
IPL, and CM can be deconvoluted by measuring the kinetic constants for each 
activity in the future. Additionally in the future structural determination of the PchA 
wild type and D310E could provide insight into the new hypothesis for reaction 
mechanism catalyzed by this mutant. The ICS MenF, salicylate synthase Irp9, and 
MbtI can serve as models for structure solution of PchA and D310E. 
 PchA, PchB, and chorismate have been prepared for high throughput 
screening, where various chemical compounds are tested for their ability to inhibit the 
salicylate synthesis in vitro. The compounds with highest IC50 against PchA or PchB 
will provide a starting point for designing antimicrobial agents for P. aeruginosa 
infection. Further improvement of these compounds could benefit from the detailed 
analyses of the reaction mechanism and structure of salicylate biosynthetic enzymes, 
PchA and PchB.  
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